<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71437</article-id><article-id pub-id-type="doi">10.7554/eLife.71437</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>The E3 ligase Thin controls homeostatic plasticity through neurotransmitter release repression</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-277617"><name><surname>Baccino-Calace</surname><given-names>Martin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4143-4166</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244349"><name><surname>Schmidt</surname><given-names>Katharina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2797-9952</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-68490"><name><surname>Müller</surname><given-names>Martin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1624-6761</contrib-id><email>Martin.Mueller@mls.uzh.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>Department of Molecular Life Sciences, University of Zurich</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution>Zurich Ph.D. Program in Molecular Life Sciences</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>Neuroscience Center Zurich, University of Zurich/ETH Zurich</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a7f6w43</institution-id><institution>Max Planck Institute of Experimental Medicine</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Chen</surname><given-names>Lu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>07</day><month>07</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e71437</elocation-id><history><date date-type="received" iso-8601-date="2021-06-19"><day>19</day><month>06</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-07-06"><day>06</day><month>07</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-06-16"><day>16</day><month>06</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.06.16.448554"/></event></pub-history><permissions><copyright-statement>© 2022, Baccino-Calace et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Baccino-Calace et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71437-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-71437-figures-v2.pdf"/><abstract><p>Synaptic proteins and synaptic transmission are under homeostatic control, but the relationship between these two processes remains enigmatic. Here, we systematically investigated the role of E3 ubiquitin ligases, key regulators of protein degradation-mediated proteostasis, in presynaptic homeostatic plasticity (PHP). An electrophysiology-based genetic screen of 157 E3 ligase-encoding genes at the <italic>Drosophila</italic> neuromuscular junction identified <italic>thin</italic>, an ortholog of human <italic>tripartite motif-containing 32</italic> (<italic>TRIM32</italic>), a gene implicated in several neurological disorders, including autism spectrum disorder and schizophrenia. We demonstrate that <italic>thin</italic> functions presynaptically during rapid and sustained PHP. Presynaptic <italic>thin</italic> negatively regulates neurotransmitter release under baseline conditions by limiting the number of release-ready vesicles, largely independent of gross morphological defects. We provide genetic evidence that <italic>thin</italic> controls release through <italic>dysbindin</italic>, a schizophrenia-susceptibility gene required for PHP. Thin and Dysbindin localize in proximity within presynaptic boutons, and Thin degrades Dysbindin in vitro. Thus, the E3 ligase Thin links protein degradation-dependent proteostasis of Dysbindin to homeostatic regulation of neurotransmitter release.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>homeostatic plasticity</kwd><kwd>neurotransmitter release</kwd><kwd>proteostasis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>PP00P3-15</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Martin</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>SynDegrade-679881</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Martin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>An electrophysiology-based genetic screen in <italic>Drosophila</italic> identified a role for the E3 ligase Thin in presynaptic homeostatic plasticity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Nervous system function is remarkably robust despite continuous turnover of the proteins determining neural function. Work in nervous systems of various species has established that evolutionarily conserved homeostatic signaling systems maintain neural activity within adaptive ranges (<xref ref-type="bibr" rid="bib38">Marder and Goaillard, 2006</xref>; <xref ref-type="bibr" rid="bib63">Turrigiano, 2008</xref>; <xref ref-type="bibr" rid="bib12">Delvendahl and Müller, 2019b</xref>). Chemical synapses evolved mechanisms that compensate for neural activity perturbations through homeostatic regulation of neurotransmitter release (‘presynaptic homeostatic plasticity’, PHP) (<xref ref-type="bibr" rid="bib50">Petersen et al., 1997</xref>; <xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>; <xref ref-type="bibr" rid="bib12">Delvendahl and Müller, 2019b</xref>), or neurotransmitter receptors (synaptic scaling) (<xref ref-type="bibr" rid="bib62">Turrigiano et al., 1998</xref>). Several studies have established links between homeostatic control of synaptic transmission and neurological disorders, such as autism spectrum disorder (<xref ref-type="bibr" rid="bib42">Mullins et al., 2016</xref>), schizophrenia (<xref ref-type="bibr" rid="bib70">Wondolowski and Dickman, 2013</xref>), or amyotrophic lateral sclerosis (<xref ref-type="bibr" rid="bib49">Perry et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Orr et al., 2020</xref>).</p><p>Synaptic proteins are continuously synthesized and degraded, resulting in half-lives ranging from hours to months (<xref ref-type="bibr" rid="bib8">Cohen et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Fornasiero et al., 2018</xref>). The ubiquitin–proteasome system (UPS) is a major protein degradation pathway that controls protein homeostasis, or proteostasis. E3 ubiquitin ligases confer specificity to the UPS by catalyzing the ubiquitination of specific target proteins, thereby regulating their function or targeting them for proteasomal degradation (<xref ref-type="bibr" rid="bib73">Zheng and Shabek, 2017</xref>). Synaptic proteostasis, and E3 ligases in particular, have been implicated in various neurological disorders (<xref ref-type="bibr" rid="bib21">George et al., 2018</xref>). However, our understanding of the role of E3 ligases in the regulation of synaptic transmission is very limited. While several E3 ligases have been linked to postsynaptic forms of synaptic plasticity (<xref ref-type="bibr" rid="bib24">Hegde, 2010</xref>), only three E3 ligases, Scrapper (<xref ref-type="bibr" rid="bib71">Yao et al., 2007</xref>), Highwire (<xref ref-type="bibr" rid="bib57">Russo et al., 2019</xref>), and Ariadne-1 (<xref ref-type="bibr" rid="bib54">Ramírez et al., 2021</xref>) have been implicated in the regulation of presynaptic function. Moreover, a systematic investigation of E3 ligase function in the context of synaptic transmission is lacking.</p><p>PHP stabilizes synaptic efficacy in response to neurotransmitter receptor perturbation at neuromuscular junctions (NMJs) of <italic>Drosophila melanogaster</italic> (<xref ref-type="bibr" rid="bib50">Petersen et al., 1997</xref>; <xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>; <xref ref-type="bibr" rid="bib12">Delvendahl and Müller, 2019b</xref>), mice (<xref ref-type="bibr" rid="bib67">Wang et al., 2010</xref>), rats (<xref ref-type="bibr" rid="bib52">Plomp et al., 1992</xref>), and humans (<xref ref-type="bibr" rid="bib10">Cull-Candy et al., 1980</xref>). Furthermore, there is recent evidence for PHP in the mouse cerebellum (<xref ref-type="bibr" rid="bib11">Delvendahl et al., 2019a</xref>). The molecular mechanisms underlying PHP are best understood at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib12">Delvendahl and Müller, 2019b</xref>), because this system is amenable to electrophysiology-based genetic screens (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>; <xref ref-type="bibr" rid="bib40">Müller et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Delvendahl and Müller, 2019b</xref>). At this synapse, pharmacological or genetic impairment of glutamate receptor (GluR) activity triggers a retrograde signal that enhances presynaptic release, thereby precisely compensating for this perturbation (<xref ref-type="bibr" rid="bib50">Petersen et al., 1997</xref>; <xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>). PHP can be induced within minutes after pharmacological receptor impairment (<xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>). Severing the motoneuron axons forming the <italic>Drosophila</italic> NMJ in close vicinity of the NMJ does not impair PHP upon pharmacological receptor impairment (<xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>), indicating that the mechanisms underlying rapid PHP expression act locally at the synapse. Moreover, pharmacological inhibition of protein synthesis by cycloheximide does not affect PHP after pharmacological receptor impairment at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>), suggesting that de novo protein synthesis is not required for PHP expression on rapid time scales. By contrast, acute or sustained disruption of the presynaptic proteasome blocks PHP (<xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>), demonstrating that presynaptic UPS-mediated proteostasis is required for PHP. Furthermore, genetic data link UPS-mediated degradation of two proteins, Dysbindin and RIM, to PHP (<xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). Yet, it is currently unclear how the UPS controls PHP. Based on the critical role of E3 ligases in UPS function, we hypothesized an involvement of E3 ligases in PHP.</p><p>Here, we realized an electrophysiology-based genetic screen to systematically analyze the role of E3 ligases in neurotransmitter release regulation and PHP at the <italic>Drosophila</italic> NMJ. This screen discovered that the E3 ligase-encoding gene <italic>thin</italic>, an ortholog of human <italic>TRIM32</italic> (<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Domsch et al., 2013</xref>), controls neurotransmitter release and PHP. We provide evidence that <italic>thin</italic> regulates the number of release-ready synaptic vesicles through <italic>dysbindin</italic>, a gene linked to PHP in <italic>Drosophila</italic> and schizophrenia in humans.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>An electrophysiology-based genetic screen identifies <italic>thin</italic></title><p>To systematically test the roles of E3 ligases in PHP, we first generated a list of genes predicted to encode E3 ligases in <italic>D. melanogaster</italic>. To this end, we browsed the <italic>D. melanogaster</italic> genome for known E3-ligase domains (<xref ref-type="bibr" rid="bib17">Du et al., 2011</xref>; <xref ref-type="bibr" rid="bib27">Ketosugbo et al., 2017</xref>). Moreover, we included homologs of predicted vertebrate E3 ligases (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). This approach yielded 281 putative E3 ligase-encoding genes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), significantly higher than previously predicted for <italic>D. melanogaster</italic> (207 genes; <xref ref-type="bibr" rid="bib17">Du et al., 2011</xref>). To explore the relationship between the number of E3 ligase-encoding genes and the number of protein-coding genes, we plotted the number of putative E3 ligase-encoding genes over the total protein-coding gene number of three species and compared it to the relationship between protein kinase-encoding genes and genome size (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The relatively constant ratio between the predicted number of E3 ligase-encoding genes and genome size across species (~0.02–0.03; <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib27">Ketosugbo et al., 2017</xref>), suggests an evolutionarily conserved stoichiometry between E3 ligases and target proteins, similar to protein kinases (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Hence, a core mechanism of the UPS – protein ubiquitination – is likely conserved in <italic>D. melanogaster</italic>.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>An electrophysiology-based genetic screen identifies <italic>thin</italic> as a synaptic homeostasis gene.</title><p>(<bold>A</bold>) The number of putative E3 ubiquitin ligase-encoding genes (E3) and protein kinase-encoding genes (PK) as a function of total protein-coding gene number of <italic>C. cerevisiae</italic>, <italic>D. melanogaster</italic>, and <italic>H. sapiens</italic>. Note the similar relationship between E3 number or PK number and total protein-coding gene number across species. (<bold>B</bold>) <italic>Top</italic>: 157 E3 ligase-encoding genes and 11 associated genes (180 lines; presynaptic RNA<sub>i</sub> expression, <italic>elav<sup>c155</sup></italic>-Gal4&gt;<italic>UAS RNA<sub>i</sub></italic>, or mutants, note that some genes were targeted by more than one line) were tested using two-electrode voltage clamp analysis at the <italic>Drosophila</italic> neuromuscular junction (NMJ) in the presence of the glutamate receptor (GluR) antagonist philanthotoxin-443 (‘PhTX’) to assess presynaptic homeostatic plasticity (PHP) (see Materials and methods). <italic>Bottom</italic>: Exemplary miniature excitatory postsynaptic potentials (mEPSPs) and action potential (AP)-evoked excitatory postsynaptic currents (EPSCs) recorded from wild-type (WT), WT in the presence of PhTX (‘WT + PhTX’), and a PHP mutant in the presence of PhTX (‘PHP mutant + PhTX’). Note the decrease in mEPSP amplitude after PhTX treatment, indicating GluR inhibition, and the similar EPSC amplitude between WT and WT + PhTX, suggesting PHP. Small EPSC amplitudes in the presence of PhTX (red arrow) imply a defect in PHP or baseline synaptic transmission. (<bold>C</bold>) Histogram of mean mEPSP amplitudes for each transgenic or mutant line (mean <italic>n</italic> = 4 NMJs per line, range 3–12; <italic>N</italic> = 180 lines) following PhTX treatment. WT averages under control conditions (‘WT’, <italic>n</italic> = 16) and in the presence of PhTX (‘WT + PhTX’, <italic>n</italic> = 16) are shown as gray and black arrows, respectively. (<bold>D</bold>) Histogram of mean EPSC amplitudes (as in C). The red bars indicate transgenic or mutant lines with EPSC amplitudes significantly different from WT in the presence of PhTX (black arrow). (<bold>E</bold>) Volcano plot of the ratio between the mean EPSC amplitude of a transgenic or mutant line and WT (‘EPSC<sub>x</sub>/EPSC<sub>WT</sub>’) in the presence of PhTX (p values from one-way analysis of variance [ANOVA] with Tukey’s multiple comparisons). Transgenic or mutant lines with mean EPSC amplitude changes with p ≤ 0.01 (dashed line) are shown in red. A deletion in the gene <italic>thin</italic> (<italic>CG15105; thin<sup>ΔA</sup></italic>; <xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>) that was selected for further analysis is shown as a filled red circle. One-way ANOVA with Tukey’s multiple comparisons was performed for statistical testing (<bold>C–E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Generation and prioritization of the E3 ligase-encoding gene list.</title><p>(<bold>A</bold>) Flow chart describing the prioritization process of the E3 list. <italic>Generation</italic>: First, we used the Gene Ontology (GO) search of Flybase (<xref ref-type="bibr" rid="bib33">Larkin et al., 2021</xref>) to identify genes annotated to encode for proteins with E3 ubiquitin ligase domains within the <italic>Drosophila melanogaster</italic> genome. This yielded an initial list of 221 genes, including confirmed and putative E3 ligase-encoding genes, similar to previous estimates (<xref ref-type="bibr" rid="bib17">Du et al., 2011</xref>). Next, we added genes encoding domains contributing to the formation of the E3 complex, including the F-box domain, the Cullin domain, the N-recognin domain, the SKP1 domain, and the U-box domain. Subsequently, we searched human E3 ligase-encoding genes (<xref ref-type="bibr" rid="bib34">Li et al., 2008</xref>) for <italic>D. melanogaster</italic> orthologs using the <italic>Drosophila</italic> RNAi Screening Center Integrative Ortholog Prediction Tool (DIOPT; version 8.0; <ext-link ext-link-type="uri" xlink:href="http://www.flyrnai.org/diopt">http://www.flyrnai.org/diopt</ext-link>) (<xref ref-type="bibr" rid="bib25">Hu et al., 2011</xref>). In total, this approach identified 281 putative E3 ligase-encoding genes in the <italic>D. melanogaster</italic> genome. <italic>Prioritization</italic>: We used a combination of four different criteria to create a score (normalized to max.) to prioritize the E3 list for screening the most relevant candidates. First, we prioritized for evolutionary conservation according to the overall DIOPT score of each putative E3 ligase-encoding gene with regard to its human ortholog (<xref ref-type="bibr" rid="bib25">Hu et al., 2011</xref>) (score 1, ‘<italic>ω</italic><sub>1</sub>’). Second, we prioritized for genes with predicted central nervous system expression based on transcriptomics data from modENCODE (<xref ref-type="bibr" rid="bib39">modENCODE Consortium et al., 2009</xref>) and FlyAtlas (<xref ref-type="bibr" rid="bib5">Chintapalli et al., 2007</xref>) (<italic>ω</italic><sub>2</sub>). Third, we prioritized for genes encoding for proteins predicted to interact with synaptic proteins. In short, we created a literature-based list of known synaptic genes and calculated an interaction probability between each putative E3 ligase-encoding gene and all synaptic genes using STRING (<xref ref-type="bibr" rid="bib65">von Mering et al., 2005</xref>) (<italic>ω</italic><sub>3</sub>). Fourth, we considered the probability of synaptic function predicted by machine-learning based analysis of transcriptomics data (<xref ref-type="bibr" rid="bib46">Pazos Obregón et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Pazos Obregón et al., 2019</xref>) (<italic>ω</italic><sub>4</sub>). The list of putative E3 ligase-encoding genes was sorted according to the sum of the four scores for each gene. (<bold>B</bold>) Distribution of the total score (summed weights) for all putative E3 ligase-encoding genes. The red bars indicate the lines selected for analysis (arbitrary threshold). In addition, genes encoding E3 ligases with known targets implicated in synaptic transmission or synaptic plasticity based on previously published data were added to our screen. Altogether, we tested 157 out of the 281 genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Homology between Thin and TRIM family proteins.</title><p>(<bold>A</bold>) Schematic representation of the domain organization of <italic>Drosophila</italic> Thin isoforms and its closest human TRIM family homologs. <italic>thin</italic> encodes an E3 ligase with a N-terminal tripartite motif (TRIM), containing one RING-finger domain (black triangle), a zinc-finger domain (B box, partially conserved, gray oval), and coiled-coil region (gray triangle), followed by disordered domains (brown ovals). Four out of five Thin isoforms harbor six C-terminal NHL repeats (red boxes). All TRIM proteins contain a N-terminal TRIM and are grouped into different families based on their C-terminal domain composition (<xref ref-type="bibr" rid="bib59">Short and Cox, 2006</xref>). TRIM proteins with C-terminal NHL repeats form family C-VII. Hence, Thin’s domain composition is most similar to TRIM proteins of the C-VII family. Within the C-VII TRIM family, TRIM32 is the only member that harbors NHL repeats in addition to the TRIM motif. Other TRIM proteins of this family contain an additional Filamin domain (blue square), which is absent in Thin. Thus, Thin’s domain composition resembles the one of TRIM32, suggesting that TRIM32 is the closest human homolog of Thin. Alignment of RING domains (<bold>B</bold>) and NHL domains (<bold>C</bold>) of Thin and human TRIM family C-VII members implies evolutionary conservation of both domains between Thin and TRIM C-VII members (<xref ref-type="bibr" rid="bib45">Ozato et al., 2008</xref>). The results of our analysis agree with <xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig1-figsupp2-v2.tif"/></fig></fig-group><p>After prioritizing for evolutionarily conserved genes that were shown or predicted to be expressed in the nervous system (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), we investigated PHP after genetic perturbation of 157 putative E3 ligase genes and 11 associated genes (180 lines, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, <xref ref-type="fig" rid="fig1">Figure 1B</xref>). Specifically, we recorded spontaneous miniature excitatory postsynaptic potentials (mEPSPs) and action potential (AP)-evoked excitatory postsynaptic currents (EPSCs) after applying subsaturating concentrations of the GluR antagonist philanthotoxin-443 (PhTX) for 10 min (20 μM; extracellular Ca<sup>2+</sup> concentration, 1.5 mM). At wild-type (WT) NMJs, PhTX treatment significantly reduced mEPSP amplitude compared to untreated controls (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, black and gray arrows), indicating GluR perturbation. By contrast, AP-evoked EPSC amplitudes were similar between PhTX-treated and untreated WT NMJs (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, black and gray arrows). Together with a reduction in mEPSP amplitude, a similar EPSC amplitude suggests a homeostatic increase in neurotransmitter release after PhTX treatment in WT, consistent with PHP (<xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>). PhTX also reduced mean mEPSP amplitudes in the 180 transgenic or mutant lines (either presynaptic/neuronal RNAi expression, <italic>elav<sup>c155</sup>-Gal4&gt;UAS</italic> RNAi; or mutations within the respective coding sequence, see Materials and methods) compared to untreated WT controls (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Moreover, the mean EPSC amplitude of the majority of the tested lines did not differ significantly from the mean WT EPSC amplitudes recorded at PhTX-treated NMJs (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, compare white bars with black arrow). The combination of a decrease in mEPSP amplitude and largely unchanged EPSC amplitude indicates that the majority of the tested lines likely display PHP. We also identified 21 transgenic or mutant lines with significantly smaller EPSC amplitudes compared to PhTX-treated WT NMJs, and two lines with increased EPSC amplitudes (<xref ref-type="fig" rid="fig1">Figure 1D, E</xref>, red data). The lines with smaller EPSC amplitudes represent candidate transgenic or mutant lines with disrupted PHP. One of the mutant lines with significantly smaller EPSC amplitudes in the presence of PhTX was a previously described deletion of the gene <italic>thin/abba</italic> (<italic>tn</italic>, <italic>CG15105</italic>), henceforth called <italic>thin</italic> (<italic>thin<sup>ΔA</sup></italic>; <xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>; <xref ref-type="fig" rid="fig1">Figure 1E</xref>, filled red data). <italic>thin</italic> encodes an E3 ligase with a N-terminal tripartite motif (TRIM), which contains one RING-finger domain, two zinc-finger domains (B1 box and B2 box), and its associated coiled-coil region, followed by a disordered region and C-terminal NHL repeats (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Based on this domain composition, <italic>thin</italic> likely represents the <italic>Drosophila</italic> ortholog of human <italic>TRIM32</italic> (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>), consistent with earlier work (<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>). <italic>thin</italic> was selected for further analysis.</p></sec><sec id="s2-2"><title>Presynaptic <italic>thin</italic> promotes PHP</title><p>In the genetic screen, we compared synaptic transmission between a given genotype and WT controls in the presence of PhTX (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>). Hence, the small EPSC amplitude of <italic>thin<sup>ΔA</sup></italic> mutants seen after PhTX application could be either due to impaired PHP, or a defect in baseline synaptic transmission. To distinguish between these possibilities, we next quantified synaptic transmission in the absence and presence of PhTX in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Similar to WT controls, PhTX application significantly reduced mEPSC amplitude by ~40% in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>), suggesting similar receptor impairment. At WT synapses, EPSC amplitudes were similar in the absence and presence of PhTX (<xref ref-type="fig" rid="fig2">Figure 2A, C</xref>). In combination with the decrease in mEPSC amplitude (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), PhTX incubation increased quantal content (EPSC amplitude/mEPSC amplitude) in WT (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), indicating homeostatic release potentiation. By contrast, PhTX treatment significantly reduced EPSC amplitudes in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2A, C</xref>) and did not increase quantal content (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These data show that <italic>thin</italic> is required for acute PHP expression.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Homeostatic plasticity requires presynaptic <italic>thin</italic>.</title><p>(<bold>A</bold>) Representative excitatory postsynaptic currents (EPSCs) (individual sweeps and averages are shown in light colors and black, respectively), and mEPSCs (insets) of wild-type (WT) (gray), <italic>thin<sup>ΔA</sup></italic> mutants (red), presynaptic <italic>thin</italic> expression in <italic>thin<sup>ΔA</sup></italic> mutants (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS</italic>-<italic>thin</italic>; <italic>thin<sup>ΔA</sup></italic>, ‘<italic>thin<sup>ΔA</sup></italic> pre. rescue’, blue), and postsynaptic <italic>thin</italic> expression in <italic>thin<sup>ΔA</sup></italic> mutants (<italic>24B-Gal4</italic>&gt;<italic>UASthin; thin<sup>ΔA</sup></italic>, ‘<italic>thin<sup>ΔA</sup></italic> post. rescue’, green) in the absence and presence of philanthotoxin-443 (PhTX) (‘+PhTX’, darker colors). Stimulation artifacts were blanked for clarity. Note the decreased EPSC amplitudes at PhTX-treated <italic>thin<sup>ΔA</sup></italic> mutant neuromuscular junctions (NMJs) and <italic>thin<sup>ΔA</sup></italic> post. rescue NMJs, indicating impaired presynaptic homeostatic plasticity (PHP). Mean mEPSC amplitudes (<bold>B</bold>), EPSC amplitudes (<bold>C</bold>), quantal content after PhTX treatment normalized to the respective untreated control (<bold>D</bold>), in the absence (‘−’) and presence (‘+’) of PhTX, as well as baseline quantal content of the indicated genotypes in the absence (‘−’) of PhTX normalized to WT (<bold>E</bold>). Note that PhTX did not enhance quantal content in <italic>thin<sup>ΔA</sup></italic> mutants (<bold>D</bold>), indicating impaired PHP. Also note the increased quantal content under baseline conditions in <italic>thin<sup>ΔA</sup></italic> mutants (<bold>E</bold>), suggesting increased release. The PHP and baseline synaptic transmission defects are restored upon presynaptic <italic>thin</italic> expression in the mutant background. Mean ± standard error of the mean (SEM) (WT − PhTX: <italic>n</italic> = 14, WT + PhTX: <italic>n</italic> = 13; <italic>thin<sup>ΔA</sup></italic> − PhTX: <italic>n</italic> = 18; <italic>thin<sup>ΔA</sup></italic> + PhTX: <italic>n</italic> = 21; pre. res. − PhTX: <italic>n</italic> = 11; pre. res.+ PhTX: <italic>n</italic> = 10; post. res. − PhTX: <italic>n</italic> = 25; post. res.+ PhTX: <italic>n</italic> = 24); *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; n.s.: not significant; two-way analysis of variance (ANOVA) followed by Tukey’s post hoc test (<bold>B–D</bold>) and one-way ANOVA with Tukey’s multiple comparisons (<bold>E</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Sustained homeostasis is impaired in <italic>thin</italic> mutants.</title><p>(<bold>A</bold>) Representative excitatory postsynaptic currents (EPSCs) (individual sweeps and averages are shown in light colors and black, respectively), and mEPSCs (insets) of wild-type (WT) (gray), <italic>GluRIIA<sup>SP16</sup></italic> mutants (dark gray), <italic>thin<sup>ΔA</sup></italic> mutants (red), and <italic>thin<sup>ΔA</sup></italic>, <italic>GluRIIA<sup>SP16</sup></italic> double mutants (dark red). Stimulation artifacts were blanked for clarity. Mean mEPSC amplitudes (<bold>B</bold>), EPSC amplitudes (<bold>C</bold>), and quantal content (<bold>D</bold>) of the indicated genotypes. Note that there is no quantal content increase in <italic>thin<sup>ΔA</sup></italic>, <italic>GluRIIA<sup>SP16</sup></italic> compared to <italic>thin<sup>ΔA</sup></italic>, indicating impaired presynaptic homeostatic plasticity (PHP). The similarity between mEPSC amplitudes in <italic>GluRIIA<sup>SP16</sup></italic> and <italic>thin<sup>ΔA</sup></italic>, <italic>GluRIIA<sup>SP16</sup></italic> mutants may indicate reduced GluR levels in <italic>thin<sup>ΔA</sup></italic> mutants. Mean ± standard error of the mean (SEM) (WT: <italic>n</italic> = 11; <italic>GluRIIA<sup>SP16</sup></italic>: <italic>n</italic> = 13; <italic>thin<sup>ΔA</sup></italic>: <italic>n</italic> = 16; <italic>thin<sup>ΔA</sup></italic>, <italic>GluRIIA<sup>SP16</sup></italic>: <italic>n</italic> = 14); *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; n.s.: not significant; two-way analysis of variance (ANOVA) followed by Tukey’s post hoc test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title><p>Sustained homeostasis is impaired in <italic>thin</italic> mutants.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig2-figsupp1-v2.tif"/></fig></fig-group><p>To test if presynaptic or postsynaptic <italic>thin</italic> promotes PHP, and if the PHP defect is indeed caused by loss of <italic>thin</italic>, we assessed PHP after presynaptic or postsynaptic expression of a <italic>thin</italic> transgene in the <italic>thin<sup>ΔA</sup></italic> mutant background. PhTX treatment significantly reduced mEPSC amplitudes after neural/presynaptic (<italic>elav<sup>c155</sup>-Gal4</italic>) or postsynaptic (<italic>24B-Gal4</italic>) expression of <italic>thin</italic> (<italic>UAS-thin</italic>) in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>). After presynaptic <italic>thin</italic> expression in <italic>thin<sup>ΔA</sup></italic> mutants (presynaptic rescue or ‘pre. rescue’), quantal content was significantly increased upon PhTX treatment (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, blue data), and EPSC amplitudes were restored toward control levels in the absence of PhTX (<xref ref-type="fig" rid="fig2">Figure 2A, C</xref>, blue data). Note that the partial rescue may be due to <italic>thin</italic> overexpression or defects in muscle architecture (<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>). By contrast, quantal content was similar between PhTX-treated and untreated NMJs after postynaptic <italic>thin</italic> expression in the <italic>thin<sup>ΔA</sup></italic> mutant background (postsynaptic rescue or ‘post. rescue’; <xref ref-type="fig" rid="fig2">Figure 2D</xref>, green data), and PhTX application reduced EPSC amplitudes (<xref ref-type="fig" rid="fig2">Figure 2A, C</xref>, green data). Thus, presynaptic, but not postsynaptic <italic>thin</italic> expression enhanced quantal content after PhTX treatment in the <italic>thin<sup>ΔA</sup></italic> mutant background (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), implying a presynaptic role for <italic>thin</italic> in PHP.</p><p>We also noted a decrease in mEPSC amplitude in <italic>thin<sup>ΔA</sup></italic> mutants compared to WT in the absence of PhTX (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>), which is most likely due to impaired muscle architecture in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Domsch et al., 2013</xref>). Postsynaptic, but not presynaptic <italic>thin</italic> expression, significantly increased mEPSC amplitudes toward WT levels in the <italic>thin<sup>ΔA</sup></italic> mutant background (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>), suggesting that postsynaptic <italic>thin</italic> is required for normal mEPSC amplitude levels. Furthermore, <italic>thin<sup>ΔA</sup></italic> mutants displayed a significant increase in quantal content compared to WT under baseline conditions in the absence of PhTX (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), which was rescued by presynaptic, but not postsynaptic <italic>thin</italic> expression (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). These data are consistent with the idea that presynaptic <italic>thin</italic> represses release under baseline conditions (see Figure 4, Figure 6). By extension, the increased release under baseline conditions in <italic>thin<sup>ΔA</sup></italic> mutants may partially occlude PHP in response to receptor perturbation (see Discussion).</p><p>At the <italic>Drosophila</italic> NMJ, genetic ablation of the GluRIIA subunit in <italic>GluRIIA<sup>SP16</sup></italic> mutants reduces quantal size and induces sustained PHP (<xref ref-type="bibr" rid="bib50">Petersen et al., 1997</xref>). To test if <italic>thin</italic> is required for sustained PHP expression, we generated recombinant flies carrying the <italic>GluRIIA<sup>SP16</sup></italic> and the <italic>thin<sup>ΔA</sup></italic> mutation (‘<italic>GluRIIA<sup>SP16</sup></italic>, <italic>thin<sup>ΔA</sup></italic>’). While we observed a significant increase in quantal content in <italic>GluRIIA<sup>SP16</sup></italic> mutants compared to wild type (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), indicating sustained PHP expression, there was no increase in quantal content in <italic>GluRIIA<sup>SP16</sup></italic>, <italic>thin<sup>ΔA</sup></italic> double mutants compared to <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Hence, <italic>thin</italic> is also necessary for sustained PHP expression, providing independent evidence for its role in homeostatic release regulation.</p></sec><sec id="s2-3"><title>Changes in NMJ development unlikely underlie the PHP defect in <italic>thin</italic> mutants</title><p>The PHP defect and the release enhancement under baseline conditions after presynaptic <italic>thin</italic> perturbation may arise from impaired synaptic development. To test this possibility, we investigated NMJ morphology in <italic>thin</italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Immunostainings with an antibody detecting neuronal membrane (anti-horseradish peroxidase, ‘HRP’; <xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib26">Jan and Jan, 1982</xref>) revealed no changes in HRP area in <italic>thin<sup>ΔA</sup></italic> mutants or after presynaptic rescue (<italic>thin<sup>ΔA</sup>; elav<sup>c155</sup>-Gal4&gt;UAS</italic> thin), and a trend toward increased HRP area after postsynaptic rescue (<italic>thin<sup>ΔA</sup>; 24BGal4&gt;UAS</italic> thin) compared to WT (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Analysis of the active-zone marker Bruchpilot (anti-Bruchpilot, ‘Brp’; <xref ref-type="bibr" rid="bib29">Kittel et al., 2006</xref>) uncovered no changes in Brp puncta number per NMJ in <italic>thin<sup>ΔA</sup></italic> mutants or after presynaptic rescue, and a slight increase after postsynaptic rescue compared to WT (<xref ref-type="fig" rid="fig3">Figure 3A, C</xref>). Brp density (Brp puncta #/HRP area) was unchanged in <italic>thin<sup>ΔA</sup></italic> mutants or after postsynaptic rescue, and slightly increased after presynaptic rescue (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Finally, we observed a decrease in Brp puncta intensity in <italic>thin<sup>ΔA</sup></italic> mutants and upon presynaptic rescue (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). In principle, these morphological alterations could be related to the PHP defect, or the release enhancement seen in <italic>thin<sup>ΔA</sup></italic> mutants. However, while HRP area and Brp puncta number were unchanged in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3B, C</xref>), PHP was blocked, and baseline synaptic transmission enhanced (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In addition, postsynaptic <italic>thin</italic> expression in WT induced an increase in HRP area and Brp puncta number (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C</xref>), but neither impaired PHP nor enhanced release (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F–K</xref>). Furthermore, Brp intensity was decreased after presynaptic rescue (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) and postsynaptic <italic>thin</italic> overexpression in WT (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>), whereas synaptic physiology was unchanged in these genotypes (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F–K</xref>). Conversely, Brp intensity was unchanged after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-thin<sup>RNAi</sup></italic>), while PHP was blocked and baseline synaptic transmission enhanced (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Collectively, these data suggest that the morphological changes seen after <italic>thin</italic> perturbation are separable from synaptic physiology. Thus, although we cannot rule out that changes in NMJ morphology contribute to the PHP defect or the increase in release in <italic>thin</italic> mutants, we consider this possibility unlikely (see Discussion).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Slight alterations in neuromuscular junction (NMJ) morphology upon genetic <italic>thin</italic> manipulations.</title><p>(<bold>A</bold>) Maximum intensity projection of a wild-type (WT) (left) and <italic>thin<sup>ΔA</sup></italic> mutant NMJ (right) (muscle 6) stained against the <italic>Drosophila</italic> neuronal membrane marker anti-HRP (‘HRP’) and the active-zone marker Bruchpilot (‘Brp’); scale bar, 10 µm. Mean HRP area per NMJ ‘HRP area’ (<bold>B</bold>), Brp puncta number per NMJ ‘Brp puncta #’ (<bold>C</bold>), Brp puncta number/HRP area per NMJ ‘Brp density’ (<bold>D</bold>), and Brp puncta fluorescence intensity (<bold>E</bold>) of the indicated genotypes (‘Postsynaptic rescue’: <italic>24B-Gal4&gt;UAS-thin; thin<sup>ΔA</sup></italic>; ‘presynaptic rescue’: <italic>elav<sup>c155</sup>-Gal4&gt;UASthin; thin<sup>ΔA</sup></italic>). Although changes in the recorded parameters may contribute to changes in synaptic physiology, altered NMJ morphology was separable from synaptic physiology (see Results, Discussion, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Mean ± standard error of the mean (SEM); WT: <italic>n</italic> = 10, <italic>thin<sup>ΔA</sup></italic>: <italic>n</italic> = 8, pre. res.: <italic>n</italic> = 12; post. res.: <italic>n</italic> = 13; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; n.s.: not significant; Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Postsynaptic <italic>thin</italic> expression does not affect presynaptic homeostatic plasticity (PHP) or baseline synaptic transmission.</title><p>(<bold>A</bold>) Maximum intensity projection of a control (<italic>24B-Gal4</italic>/+, ‘<italic>muscle-Gal4</italic>’, left and <italic>24B-Gal4</italic>&gt;<italic>UAS</italic> thin, ‘<italic>muscle-Gal4</italic>&gt;<italic>UAS-thin</italic>’, right) neuromuscular junction (NMJ) (muscle 6) stained against the <italic>Drosophila</italic> neuronal membrane marker anti-HRP (‘HRP’) and the active-zone marker Bruchpilot (‘Brp’); scale bar, 20µm. Mean HRP area per NMJ (‘HRP area’) (<bold>B</bold>), Brp puncta number per NMJ (‘Brp puncta #’) (<bold>C</bold>), Brp puncta number/HRP area per NMJ ‘Brp density’ (<bold>D</bold>), and Brp puncta fluorescence intensity (<bold>E</bold>) of the indicated genotypes. <italic>24B-Gal4</italic>/+: <italic>n</italic> = 10; <italic>24B-Gal4</italic>&gt;<italic>UAS-thin</italic>: <italic>n</italic> = 12. (<bold>F</bold>) Representative excitatory postsynaptic currents (EPSCs) (individual sweeps and averages are shown in light colors and black, respectively), and mEPSCs (insets) of a control NMJ (<italic>24B-Gal4</italic>/+, ‘<italic>muscle Gal4</italic>’) in the absence (light gray) and presence of philanthotoxin-443 (PhTX) (‘+PhTX’, dark gray). Stimulation artifacts were blanked for clarity. (<bold>G</bold>) Same as in (<bold>F</bold>) for an NMJ overexpressing <italic>thin</italic> in the muscle (<italic>24B-Gal4</italic>&gt;<italic>UAS thin,</italic> ‘<italic>muscle-Gal4</italic>&gt;<italic>UAS-thin</italic>’). Mean mEPSC amplitudes (<bold>H</bold>), EPSC amplitudes (<bold>I</bold>), and quantal content (<bold>J</bold>) of control (<italic>24B-Gal4</italic>/+, ‘<italic>mGal4</italic>’, gray) and postsynaptic <italic>thin</italic> overexpression (<italic>24B-Gal4</italic>&gt;<italic>UAS</italic> thin, ‘<italic>mGal4 &gt;thin</italic>’, red) without (light colors) and after PhTX treatment (dark colors). (<bold>K</bold>) mEPSC amplitude (white) and quantal content (black) in the presence of PhTX normalized to control (without PhTX) of the indicated genotypes. PhTX treatment increased quantal content after postsynaptic <italic>thin</italic> overexpression, indicating PHP expression. Postsynaptic <italic>thin</italic> overexpression did not change baseline miniature excitatory postsynaptic potential (mEPSP) or EPSC amplitude. The increase in HRP area (<bold>B</bold>), Brp number (<bold>C</bold>), or the decrease in Brp intensity (<bold>E</bold>) upon postsynaptic <italic>thin</italic> overexpression thus do not translate into apparent changes in PHP or baseline synaptic transmission. Mean ± standard error of the mean (SEM); <italic>24B-Gal4</italic>/+ − PhTX: <italic>n</italic> = 16, <italic>24B-Gal4</italic>/++PhTX: <italic>n</italic> = 17; <italic>24B-Gal4</italic>&gt;<italic>UAS</italic> thin − PhTX: <italic>n</italic> = 13, <italic>24B-Gal4</italic>&gt;<italic>UAS</italic> thin + PhTX: <italic>n</italic> = 23; ***p &lt; 0.001; n.s.: not significant; Student’s <italic>t</italic>-test for pairwise comparison between control (<italic>24B-Gal4</italic>/+) and postsynaptic <italic>thin</italic> overexpression (<italic>24B-Gal4&gt;UAS</italic> thin).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title><p>Postsynaptic <italic>thin</italic> expression does not affect presynaptic homeostatic plasticity (PHP) or baseline synaptic transmission.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig3-figsupp1-v2.tif"/></fig></fig-group><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Thin</italic> negatively regulates release-ready vesicle number.</title><p>(<bold>A</bold>) Representative excitatory postsynaptic currents (EPSCs) (individual sweeps and averages are shown in light colors and black, respectively), and mEPSCs (insets) of controls (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-mCherry<sup>RNAi</sup></italic>, ‘Ctrl.’, gray) and presynaptic <italic>thin<sup>RNAi</sup></italic> (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>, ‘<italic>thin<sup>RNAi</sup></italic> (pre)’, red). Mean mEPSC amplitudes (<bold>B</bold>), EPSC amplitudes (<bold>C</bold>), and quantal content (<bold>D</bold>) of the indicated genotypes. (<bold>E</bold>) Representative EPSC train (60 Hz, 60 stimuli, top) and cumulative EPSC amplitudes (‘cum. EPSC’, bottom) of control and presynaptic <italic>thin<sup>RNAi</sup></italic>. The blue line is a line fit to the last 15 cum. EPSC amplitudes that was back-extrapolated to <italic>t</italic> = 0 (see Materials and methods). Mean readilyreleasable vesicle pool (RRP) size (cum. EPSC/mEPSC) (<bold>F</bold>), release probability (‘<italic>p<sub>r</sub></italic>’, EPSC1/cum. EPSC) (<bold>G</bold>), and paired-pulse ratio (‘PPR’, EPSC2/EPSC1) (<bold>H</bold>) of the indicated genotypes. Note the increase in EPSC amplitude and RRP size in presynaptic <italic>thin<sup>RNAi</sup></italic>. Mean ± standard error of the mean (SEM); Ctrl.: <italic>n</italic> = 16, <italic>thin<sup>RNAi</sup></italic>: <italic>n</italic> = 17; *p &lt; 0.05; ***p &lt; 0.001; n.s.: not significant; Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Presynaptic <italic>thin<sup>RNAi</sup></italic> expression blocks presynaptic homeostatic plasticity (PHP) and induces a slight increase in AZ number.</title><p>(<bold>A</bold>) Maximum intensity projection of a control neuromuscular junction (NMJ) (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-mCherry<sup>RNAi</sup></italic>, ‘Ctrl.’, left) and after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>, ‘<italic>thin<sup>RNAi</sup></italic>’, right) (muscle 6) stained against the <italic>Drosophila</italic> neuronal membrane marker anti-HRP (‘HRP’) and the active-zone marker Bruchpilot (‘Brp’); scale bar, 10 µm. Mean HRP area per NMJ ‘HRP area’ (<bold>B</bold>), Brp puncta number per NMJ ‘Brp puncta #’ (<bold>C</bold>), Brp puncta number/HRP area per NMJ ‘Brp density’ (<bold>D</bold>), and Brp puncta fluorescence intensity (<bold>E</bold>) of the indicated genotypes. <italic>Elav<sup>c155</sup>-Gal4&gt;UAS-mCherry<sup>RNAi</sup></italic>: <italic>n</italic> = 12, <italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>: <italic>n</italic> = 16. (<bold>F</bold>) Representative mEPSCs (top) and excitatory postsynaptic currents (EPSCs) (bottom, individual sweeps and averages are shown in light colors and black, respectively) after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>, ‘<italic>thin<sup>RNAi</sup></italic>’) in the absence (left, light red) and presence of the glutamate receptor (GluR) antagonist philanthotoxin-443 (PhTX) (right, dark red). Mean mEPSC amplitudes (<bold>G</bold>), EPSC amplitudes (<bold>H</bold>), and quantal content (<bold>I</bold>) in the absence (‘−’, light red) and presence (‘+’, dark red) of PhTX. Note that PhTX did not enhance quantal content after presynaptic <italic>thin<sup>RNAi</sup></italic> expression, indicating impaired PHP. Mean ± standard error of the mean (SEM); <italic>thin<sup>RNAi</sup></italic> − PhTX: <italic>n</italic> = 14, <italic>thin<sup>RNAi</sup></italic> + PhTX: <italic>n</italic> = 13; ***p &lt; 0.001; n.s.: not significant; Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title><p>Presynaptic <italic>thin<sup>RNAi</sup></italic> expression blocks presynaptic homeostatic plasticity (PHP) and induces a slight increase in AZ number.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig4-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title><italic>thin</italic> negatively regulates release-ready vesicle number</title><p>Having established that <italic>thin</italic> is required for acute and sustained PHP expression, we next explored the role of <italic>thin</italic> in the regulation of neurotransmitter release under baseline conditions. <italic>thin<sup>ΔA</sup></italic> mutants display increased neurotransmitter release in the absence of PhTX, and this increase in release is rescued by presynaptic <italic>thin</italic> expression (<xref ref-type="fig" rid="fig2">Figure 2</xref>). We also noted a decrease in mEPSC amplitude in <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), which may confound conclusions regarding presynaptic <italic>thin</italic> function. We therefore focused our further analyses on the effects of presynaptic <italic>thin<sup>RNAi</sup></italic> expression.</p><p>First, we tested PHP after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-thin<sup>RNAi</sup></italic>) and observed a complete PHP block (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F–I</xref>), providing independent evidence for a role of presynaptic <italic>thin</italic> in PHP. To elucidate the mechanisms through which <italic>thin</italic> negatively modulates release under baseline conditions, we probed the size of the readily releasable pool of synaptic vesicles (RRP) and neurotransmitter release probability (<italic>p</italic><sub><italic>r</italic></sub>) after presynaptic <italic>thin</italic> perturbation (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-thin<sup>RNAi</sup></italic>) significantly increased EPSC amplitudes and quantal content (<xref ref-type="fig" rid="fig4">Figure 4A, C, D</xref>), with no significant effects on mEPSC amplitudes compared to controls (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-mCherry<sup>RNAi</sup></italic>; <xref ref-type="fig" rid="fig4">Figure 4A, B</xref>), suggesting that presynaptic <italic>thin</italic> represses release, consistent with the data obtained from <italic>thin<sup>ΔA</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Note that the smaller mEPSC and EPSC amplitudes under baseline conditions after postsynaptic <italic>thin</italic> rescue (<xref ref-type="fig" rid="fig2">Figure 2B, C</xref>) compared to <italic>thin<sup>RNAi</sup></italic> (<xref ref-type="fig" rid="fig4">Figure 4B, C</xref>) are most likely due to non-endogenous postsynaptic Thin levels caused by <italic>thin</italic> overexpression in the <italic>thin<sup>ΔA</sup></italic> mutant background. Next, we estimated RRP size using cumulative EPSC amplitude analysis during high-frequency stimulation (60 Hz; <xref ref-type="bibr" rid="bib69">Weyhersmüller et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">Müller et al., 2012</xref>; <xref ref-type="fig" rid="fig4">Figure 4E</xref>). This analysis revealed a significantly larger RRP size upon presynaptic <italic>thin<sup>RNAi</sup></italic> expression compared to controls (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>), implying that presynaptic <italic>thin</italic> negatively regulates RRP size. We then estimated <italic>p<sub>r</sub></italic> based on the ratio between the first EPSC amplitude of the stimulus train and the cumulative EPSC amplitude, and observed no significant <italic>p<sub>r</sub></italic> differences between presynaptic <italic>thin<sup>RNAi</sup></italic> and controls (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). We noted that the paired-pulse ratio between the second and first EPSC amplitude during 60 Hz stimulation was slightly increased after presynaptic <italic>thin<sup>RNAi</sup></italic> expression compared to controls (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), implying a slight decrease in <italic>p<sub>r</sub></italic>. These data suggest that the increase in release after presynaptic <italic>thin<sup>RNAi</sup></italic> expression is unlikely caused by an increase in <italic>p<sub>r</sub></italic>, and that presynaptic <italic>thin<sup>RNAi</sup></italic> expression may even slightly decrease <italic>p<sub>r</sub></italic>. Presynaptic <italic>thin<sup>RNAi</sup></italic> expression also slightly increased Brp number (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), which may contribute to the increase in release after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (see Discussion). However, our analysis of <italic>thin<sup>ΔA</sup></italic> mutants implies that changes in NMJ size unlikely underlie the defects in synaptic physiology after presynaptic loss of <italic>thin</italic> (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>). Together, we conclude that presynaptic <italic>thin</italic> opposes release by limiting the number of release-ready synaptic vesicles with largely unchanged <italic>p<sub>r</sub></italic>.</p></sec><sec id="s2-5"><title>Thin localizes in proximity to Dysbindin</title><p>TRIM32, Thin’s predicted human ortholog (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>), ubiquitinates Dysbindin and targets it for degradation in cultured human cells (<xref ref-type="bibr" rid="bib37">Locke et al., 2009</xref>). <italic>dysbindin</italic>, in turn, is required for PHP at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>), and genetic evidence suggests that the UPS controls Dysbindin under baseline conditions and during PHP at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). We therefore explored the relationship between Thin and Dysbindin. First, we investigated the localization of Thin in relation to Dysbindin within synaptic boutons (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Previous studies suggest very low endogenous Dysbindin levels that preclude direct immunohistochemical analysis at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>; <xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). However, presynaptic expression of a fluorescently tagged <italic>dysbindin</italic> transgene revealed that Dysbindin localizes in close proximity to synaptic vesicle markers (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–C</xref>). The localization of fluorescently tagged Dysbindin likely overlaps with the one of endogenous Dysbindin, as its presynaptic expression rescues the PHP defect in <italic>dysbindin</italic> mutants (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>). Although we observed anti-Thin fluorescence in close proximity to Brp (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D, E</xref>), <italic>thin</italic> expression in <italic>Drosophila</italic> muscles makes it difficult to distinguish between presynaptic and postsynaptic Thin (<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D, E</xref>). This prompted us to analyze the localization of fluorescently tagged Thin, which we expressed presynaptically (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-thin<sup>mCherry</sup></italic>), in relation to Dysbindin. Presynaptic Thin<sup>mCherry</sup> partially overlapped with presynaptic fluorescently tagged Dysbindin (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-dysb<sup>venus</sup></italic>) at confocal resolution (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). The localization of fluorescently tagged Thin also likely overlaps with endogenous Thin, because presynaptic <italic>thin</italic> expression restores PHP and synaptic transmission in <italic>thin</italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2</xref>). As indicated by the line profile across a bouton (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), Dysbindin and Thin fluorescence intensity increased toward the bouton periphery (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), similar to synaptic vesicle markers, such as synapsin (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>). With stimulated emission depletion microscopy with time-gated detection (gSTED), fluorescently tagged Thin and Dysbindin appeared as distinct spots (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). To investigate the relationship between fluorescently tagged Thin and Dysbindin, we quantified the nearest-neighbor distance (NND) between Thin and Dysbindin spots (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; see Materials and methods). This analysis revealed significantly smaller NNDs between Thin<sup>mCherry</sup> and Dysb<sup>venus</sup> spots than expected from random spot distributions (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), implying a relationship between Thin and Dysbindin localization within synaptic boutons. Based on the proximity between Dysbindin and synaptic vesicle markers (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–C</xref>), these data indicate that a fraction of Thin localizes in the vicinity of Dysbindin and synaptic vesicles.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Thin localizes in close proximity to Dysbindin.</title><p>(<bold>A</bold>) Confocal maximum intensity projection of a representative neuromuscular junction (NMJ) branch (muscle 6–7) after presynaptic coexpression (<italic>elav<sup>c155</sup>-Gal4</italic>) of venus-tagged Dysbindin (<italic>UAS-venus-Dysbindin,</italic> ‘Dysb<sup>venus</sup>’, green) and mCherry-tagged Thin (<italic>UAS-mCherry-thin</italic>, ‘Thin<sup>mCherry</sup>’, magenta) detected with anti-GFP and anti-DsRed, respectively. (<bold>B</bold>) Single plane of the synaptic bouton highlighted by the white square in (<bold>A</bold>) with corresponding line profile (right). The yellow line demarks the location of the line profile. (<bold>C</bold>) gSTED image of the synaptic bouton shown in (<bold>B</bold>) with corresponding line profile (right). Scale bar, A: 5 µm; B, C: 2 µm. Note the partial overlap between Thin<sup>mCherry</sup> and Dysbindin<sup>venus</sup> at confocal and STED resolution. (<bold>D</bold>) Left: Schematic of nearest-neighbor (NND) analysis between Thin<sup>mCherry</sup> and Dysbindin<sup>venus</sup> puncta at STED resolution. Right: Thin<sup>mCherry</sup> puncta (‘+’, maximum locations, see Materials and methods) and the NNDs and locations of Dysbindin<sup>venus</sup> puncta (color code denotes NND) of a representative bouton. (<bold>E</bold>) Histogram of mean Thin<sup>mCherry</sup> − Dysbindin<sup>venus</sup> NND per bouton of the recorded gSTED data (blue), or after randomized punctum distribution (gray, see Materials and methods). <italic>N</italic> = 10 NMJs, average <italic>n</italic> = 13 boutons per NMJ for data and simulations. Observed vs. randomized NNDs, p &lt; 0.001; Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Dysbindin and Synapsin distribute in the periphery of synaptic boutons, endogenous Thin localizes close to Brp, and presynaptic <italic>dysbindin</italic> overexpression does not affect neuromuscular junction (NMJ) morphology.</title><p>(<bold>A</bold>) Confocal maximum intensity projection of a representative NMJ branch (muscle 6–7) after presynaptic expression (<italic>elav<sup>c155</sup>-Gal4</italic>) of venus-tagged Dysbindin (<italic>UAS-venus-dysbindin,</italic> ‘Dysb<sup>venus</sup>’) stained with anti-GFP (green, ‘Dysb<sup>venus</sup>’) and anti-Synapsin (magenta, ‘Synapsin’). (<bold>B</bold>) Single slice of the synaptic bouton highlighted by the yellow square in (<bold>A</bold>) with corresponding line profile (right). The yellow line demarks the location of the line profile. (<bold>C</bold>) gSTED image of the synaptic bouton shown in (<bold>B</bold>) with corresponding line profile (right). Note the partial overlap between Dysb<sup>venus</sup> and the synaptic vesicle marker Synapsin at confocal and STED resolution. Scale bar, A: 4 µm; B, C: 1 µm. (<bold>D</bold>) Confocal single slice of two representative wild-type (WT) NMJ boutons (muscle 6) stained with the neuronal membrane marker anti-HRP (‘HRP’, blue), the active-zone marker Bruchpilot (anti-Brp<sup>nc82</sup>, ‘Brp’, green), and anti-Thin (‘<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>, magenta). (<bold>E</bold>) Same staining as in (<bold>D</bold>) for a <italic>thin<sup>ΔA</sup></italic> mutant NMJ. Note that some Thin puncta localize in close proximity to Brp within WT boutons (white arrowheads, D, right), suggesting presynaptic Thin puncta in the vicinity of AZs. A quantitative analysis of the relationship between anti-Thin and presynaptic markers could not be realized because of postsynaptic anti-Thin puncta in the muscle cell (not shown, <xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>). Little to no anti-Thin signal was detected at <italic>thin<sup>ΔA</sup></italic> mutant NMJs (<bold>E</bold>). Scale bar, 1 µm. (<bold>F</bold>) Mean HRP area per muscle 6/7 NMJ (‘HRP area’), Brp puncta number per NMJ (‘Brp puncta #’), Brp puncta number/HRP area per NMJ (‘Brp density’), and Brp puncta fluorescence intensity of control (<italic>elav<sup>c155</sup>-Gal4</italic>/+, ‘<italic>nGal4</italic>’, gray) and after presynaptic expression of venus-tagged Dysbindin in WT (<italic>elav<sup>c155</sup>-Gal4&gt;UAS-venus-dysbindin</italic>, ‘<italic>nGal4&gt;dysb</italic>’, blue). Note that all morphological parameters were largely unchanged after presynaptic <italic>dysbindin</italic> overexpression, implying no major changes in NMJ morphology. Mean ± standard error of the mean (SEM); <italic>nGal4</italic>: <italic>n</italic> = 9, <italic>nGal4&gt;Dysb</italic>: <italic>n</italic> = 11; n.s.: not significant; Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>.</title><p>Dysbindin and Synapsin distribute in the periphery of synaptic boutons, endogenous Thin localizes close to Brp, and presynaptic dysbindin overexpression does not affect neuromuscular junction (NMJ) morphology.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig5-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Thin localizes in close proximity to Dysbindin and Thin degrades Dysbindin in <italic>Drosophila</italic> S2 cells.</title><p>(<bold>A</bold>) Confocal images (single planes) of <italic>Drosophila</italic> S2 cells stained with anti-Dysbindin (green) and anti-Thin (magenta) under control conditions (top) and after <italic>dysbindin</italic> overexpression (<italic>UAS-venus-Dysbindin</italic>, ‘Dysb OE’, middle). Note the redistribution of Thin upon <italic>dysbindin</italic> expression resulting in overlapping Thin and Dysbindin fluorescence. Bottom: Excitation of channel 1 (anti-Dysbindin) did not produce significant fluorescence in channel 2 (anti-Thin), implying no major crosstalk between the two channels. (<bold>B</bold>) Pearson’s correlation coefficient (<italic>r</italic>) between anti-Dysbindin and anti-Thin fluorescence intensities per pixel after <italic>dysbindin</italic> overexpression (‘Dsyb OE’) (<italic>n</italic> = 22). The <italic>r</italic> density (with Gaussian fit) was obtained from simulated Thin and Dysbindin localizations after sampling random point spread function-sized chunks of the data (see Materials and methods, <italic>n</italic> = 22). The average observed <italic>r</italic> = 0.84 is significantly higher than expected from random Thin and Dysbindin localizations. (<bold>C</bold>) Representative western Blot of S2 cells transfected for 72 hr with constant levels of <italic>pUAS-venus-Dysbindin</italic> (‘Dysbindin<sup>venus</sup>’) and the indicated relative cDNA concentrations of <italic>pUAS-HA-thin</italic> (‘Thin<sup>HA</sup>’) normalized to <italic>pUAS-venus-dysbindin</italic> (‘1×’, ‘2×’). Dysbindin<sup>venus</sup> and Thin<sup>HA</sup> were detected with anti-GFP (‘a-GFP’) and anti-HA (‘a-HA’), respectively. Anti-Tubulin (‘a-Tubulin’) served as a loading control. (<bold>D</bold>) Quantification of Dysbindin<sup>venus</sup>/Tubulin fluorescence intensity at different relative Thin<sup>HA</sup> concentrations (‘1×’, ‘2×’) relative to Dysbindin<sup>venus</sup> (<italic>n</italic> = 4). Note the decrease in Dysbindin<sup>venus</sup>/Tubulin upon <italic>thin</italic> overexpression. Scale bar, A: 5 µm; B, C: 2 µm.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title><p>Thin localizes in close proximity to Dysbindin and Thin degrades Dysbindin in <italic>Drosophila</italic> S2 cells.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig5-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig5-figsupp2-v2.tif"/></fig></fig-group><p>To provide independent evidence for a relationship between Thin and Dysbindin localization, and to explore if Thin acts as an E3 ubiquitin ligase for Dysbindin in <italic>Drosophila</italic>, we turned to cultured <italic>Drosophila</italic> Schneider 2 (S2) cells. Interestingly, while anti-Thin fluorescence was homogenously distributed within S2 cells under control conditions (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>), <italic>dysbindin</italic> (<italic>dysb<sup>venus</sup></italic>) overexpression led to a redistribution of anti-Thin fluorescence into clusters that localized in close proximity to anti-Dysbindin clusters (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>). Moreover, anti-Thin and anti-Dysbindin fluorescence intensities were highly correlated (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>), suggesting a possible interaction between Thin and Dysbindin in S2 cells, similar to the <italic>Drosophila</italic> NMJ (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Next, we assessed whether Thin expression affects Dysbindin abundance in S2 cells by western blot analysis. We observed a decrease in Dysb<sup>venus</sup> levels upon increasing Thin<sup>HA</sup> expression levels (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C, D</xref>). Although we cannot exclude the possibility that Thin overexpression induced artificial Dysbindin ubiquitination by excess enzyme binding with low affinity, these data are consistent with the idea that Thin acts as an E3 ligase for Dysbindin in <italic>Drosophila</italic>, similar to TRIM32 in humans (<xref ref-type="bibr" rid="bib37">Locke et al., 2009</xref>).</p></sec><sec id="s2-6"><title><italic>thin</italic> represses release through <italic>dysbindin</italic></title><p>We next explored a possible genetic interaction between <italic>thin</italic> and <italic>dysbindin</italic> in the context of synaptic physiology. As <italic>thin</italic> and <italic>dysbindin</italic> mutants alone disrupt PHP, the analysis of double mutants would not be informative. We therefore investigated baseline synaptic transmission after presynaptic <italic>thin<sup>RNAi</sup></italic> expression in the <italic>dysbindin</italic> mutant background (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Neither presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>) in the WT background, nor in the <italic>dysb<sup>1</sup></italic> mutant background affected mEPSC amplitude (<xref ref-type="fig" rid="fig6">Figure 6A, B</xref>). While presynaptic <italic>thin<sup>RNAi</sup></italic> expression enhanced EPSC amplitude and quantal content in the WT background (<xref ref-type="fig" rid="fig6">Figure 6C, D</xref>; see also <xref ref-type="fig" rid="fig4">Figure 4</xref>), presynaptic <italic>thin<sup>RNAi</sup></italic> expression neither affected EPSC amplitude (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) nor quantal content (<xref ref-type="fig" rid="fig6">Figure 6D</xref>) in the <italic>dysb<sup>1</sup></italic> mutant background. These data provide genetic evidence that <italic>thin</italic> negatively controls release through <italic>dysbindin</italic> (<xref ref-type="fig" rid="fig6">Figure 6E</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>Thin</italic> represses release through <italic>dysbindin</italic>.</title><p>(<bold>A</bold>) Representative excitatory postsynaptic currents (EPSCs) (individual sweeps and averages are shown in light colors and black, respectively), and mEPSCs (insets) of wild-type (WT) (gray) and presynaptic <italic>thin<sup>RNAi</sup></italic> (<italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>, ‘+<italic>thin<sup>RNAi</sup></italic> (pre)’, dark gray), <italic>dysb<sup>1</sup></italic> mutants (light red), and presynaptic <italic>thin<sup>RNAi</sup></italic> in the <italic>dysb<sup>1</sup></italic> mutant background (<italic>elav<sup>c155</sup>-Gal4</italic>/Y; <italic>UAS-thin<sup>RNAi</sup></italic>/+; <italic>dysb<sup>1</sup></italic>, ‘+<italic>thin<sup>RNAi</sup></italic> (pre)’, dark red). Mean mEPSC amplitudes (<bold>B</bold>), EPSC amplitudes (<bold>C</bold>), and quantal content (<bold>D</bold>) of the indicated genotypes. Note that presynaptic <italic>thin<sup>RNAi</sup></italic> expression increases EPSC amplitude and quantal content in WT, but not in <italic>dysb<sup>1</sup></italic> mutants. Mean ± standard error of the mean (SEM); WT: <italic>n</italic> = 17, <italic>elav<sup>c155</sup>-Gal4</italic>&gt;<italic>UAS-thin<sup>RNAi</sup></italic>: <italic>n</italic> = 17, <italic>dysb<sup>1</sup></italic>: <italic>n</italic> = 12, <italic>elav<sup>c155</sup>-Gal4</italic>/Y; <italic>UAS-thin<sup>RNAi</sup></italic>/+; <italic>dysb<sup>1</sup></italic>: <italic>n</italic> = 12; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; n.s.: not significant; two-way analysis of variance (ANOVA) followed by Tukey’s post hoc test. (<bold>E</bold>) Working model: Our genetic data support a model in which <italic>thin</italic> controls neurotransmitter release (‘Release’) through negative regulation of <italic>dysbindin</italic> (‘<italic>dysb</italic>’).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-71437-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71437-fig6-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Employing an electrophysiology-based genetic screen targeting 157 E3 ligase-encoding genes at the <italic>Drosophila</italic> NMJ, we discovered that a mutation in the E3 ligase-encoding gene <italic>thin</italic> disrupts acute and sustained PHP. Presynaptic loss of <italic>thin</italic> led to increased release and RRP size, largely independent of gross synaptic morphological changes. Thin and Dysbindin localize in proximity within synaptic boutons, and biochemical evidence suggests that Thin degrades Dysbindin in vitro. Finally, presynaptic <italic>thin</italic> perturbation did not enhance release in the <italic>dysbindin</italic> mutant background, providing genetic evidence that <italic>thin</italic> represses release through <italic>dysbindin</italic>. As <italic>thin</italic> and <italic>dysbindin</italic> are required for PHP, these data are consistent with a model in which <italic>thin</italic> controls neurotransmitter release during PHP and under baseline conditions through <italic>dysbindin</italic>.</p><p>Our study represents the first systematic investigation of E3 ligase function in the context of synaptic transmission. A considerable fraction of the transgenic lines tested (11%) displayed a decrease in EPSC amplitude after PhTX treatment (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>). These E3 ligase-encoding genes may either be required for PHP and/or baseline synaptic transmission. Previous PHP screens in the same system identified PHP mutants with a hit rate of ~3% (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>; <xref ref-type="bibr" rid="bib40">Müller et al., 2011</xref>). Thus, our data indicate that E3 ligase function plays a special role in PHP and/or baseline synaptic transmission. As more transgenic or mutant lines exhibited a decrease in synaptic transmission, we conclude that the net effect of E3 ligases is to promote synaptic transmission at the <italic>Drosophila</italic> NMJ. Given the evolutionary conservation of most E3 ligase-encoding genes tested in this study (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), the results of our screen may allow predicting the roles of the tested E3 ligases in neurotransmitter release regulation in other systems.</p><p>Previous studies linked E3 ligases to synaptic development and synaptic function at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib66">Wan et al., 2000</xref>; <xref ref-type="bibr" rid="bib64">van Roessel et al., 2004</xref>). For instance, the E3 ligase <italic>highwire</italic> (<italic>hiw</italic>) restrains synaptic growth and promotes evoked synaptic transmission at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib66">Wan et al., 2000</xref>). Similarly, the deubiquitinating protease <italic>fat facets</italic> represses synaptic growth and enhances synaptic transmission (<xref ref-type="bibr" rid="bib13">DiAntonio et al., 2001</xref>). Although different molecular pathways have been implicated in <italic>hiw</italic>-dependent regulation of synaptic growth and function (<xref ref-type="bibr" rid="bib57">Russo et al., 2019</xref>), it is generally difficult to disentangle effects on synaptic morphology from synaptic function. <italic>thin</italic> and its mammalian ortholog <italic>TRIM32</italic> are required for maintaining the cytoarchitecture of muscle cells (<xref ref-type="bibr" rid="bib31">Kudryashova et al., 2005</xref>; <xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>; <xref ref-type="bibr" rid="bib6">Cijsouw et al., 2018</xref>). Hence, the changes in synaptic transmission described in the present study may be a secondary consequence of impaired muscle structure. However, presynaptic <italic>thin</italic> expression in the <italic>thin</italic> mutant background restored presynaptic function under baseline conditions and during homeostatic plasticity (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Conversely, while postsynaptic <italic>thin</italic> expression largely rescued the defects in muscle morphology in <italic>thin</italic> mutants, the defects in synaptic function persisted. These genetic data suggest that the neurotransmitter release impairment under baseline condition and during PHP in <italic>thin</italic> mutants is unlikely caused by muscular dystrophy.</p><p>We also noted a slight increase in NMJ size and/or Brp number after postsynaptic rescue in the <italic>thin</italic> mutant background (<xref ref-type="fig" rid="fig3">Figure 3</xref>) or following presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Moreover, Brp intensity was decreased in <italic>thin<sup>ΔA</sup></italic> mutants, after presynaptic rescue (<xref ref-type="fig" rid="fig3">Figure 3</xref>), or after postsynaptic <italic>thin</italic> overexpression in WT (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The reasons for the increase in NMJ size or the decrease in Brp intensity after <italic>thin</italic> manipulations are unknown, but point at a potential dysregulation of <italic>thin</italic>-dependent pathways regulating NMJ size and Brp abundance. In principle, the changes in synaptic physiology observed in these genotypes may be a consequence of altered NMJ morphology. However, the observed changes in NMJ morphology were separable from changes in synaptic physiology (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), implying that presynaptic <italic>thin</italic> regulates neurotransmitter release under baseline conditions and during homeostatic plasticity largely independent of changes in synaptic morphology.</p><p>We revealed that presynaptic <italic>thin</italic> perturbation results in enhanced neurotransmitter release (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig4">4</xref> and <xref ref-type="fig" rid="fig6">6</xref>), indicating that the E3 ligase Thin represses neurotransmitter release under baseline conditions. Notably, there are just a few molecules that have been implicated in repressing neurotransmitter release, such as the SNARE-interacting protein tomosyn (<xref ref-type="bibr" rid="bib23">Hatsuzawa et al., 2003</xref>; <xref ref-type="bibr" rid="bib4">Chen et al., 2011</xref>), or the RhoGAP crossveinless-c (<xref ref-type="bibr" rid="bib51">Pilgram et al., 2011</xref>). How could the E3 ligase Thin oppose neurotransmitter release? We discovered that <italic>dysbindin</italic> is required for the increase in release induced by presynaptic <italic>thin</italic> perturbation (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Moreover, Thin localizes in close proximity to Dysbindin in synaptic boutons (<xref ref-type="fig" rid="fig5">Figure 5</xref>), and we provide evidence that Thin likely degrades Dysbindin in vitro (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), similar to its mammalian ortholog TRIM32 (<xref ref-type="bibr" rid="bib37">Locke et al., 2009</xref>). At the <italic>Drosophila</italic> NMJ, 26S-proteasomes are transported to presynaptic boutons (<xref ref-type="bibr" rid="bib30">Kreko-Pierce and Eaton, 2017</xref>), where they degrade proteins on the minute time scale (<xref ref-type="bibr" rid="bib60">Speese et al., 2003</xref>; <xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). Previous genetic data suggest a positive correlation between Dysbindin levels and neurotransmitter release (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>; <xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>), and there is genetic evidence for rapid, UPS-dependent degradation of Dysbindin at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). In combination with these previous observations, our data are consistent with the idea that Thin opposes release by acting on Dysbindin. Although the low abundance of endogenous Dysbindin at the <italic>Drosophila</italic> NMJ precludes direct analysis of Dysbindin levels (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>), we speculate that Thin decreases Dysbindin abundance by targeting it for degradation. Alternatively, Thin may modulate Dysbindin function through mono-ubiquitination. Genetic data suggest that Dysbindin interacts with the SNARE protein SNAP25 through Snapin (<xref ref-type="bibr" rid="bib15">Dickman et al., 2012</xref>). Hence, Thin-dependent regulation of Dysbindin may modulate release via Dysbindin’s interaction with the SNARE complex.</p><p>Our study identified a crucial role for <italic>thin</italic> in PHP. How does the increase in neurotransmitter release in <italic>thin</italic> mutants under baseline conditions relate to the PHP defect? mEPSC amplitudes were decreased in <italic>thin</italic> mutants, after presynaptic and postsynaptic rescue (<xref ref-type="fig" rid="fig2">Figure 2</xref>), and largely unchanged after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The decrease in mEPSC amplitude implies a postsynaptic role of <italic>thin</italic> in regulating quantal size, possibly by regulating GluR levels (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Quantal content was increased in <italic>thin</italic> mutants, after postsynaptic rescue (<xref ref-type="fig" rid="fig2">Figure 2</xref>), and after presynaptic <italic>thin<sup>RNAi</sup></italic> expression (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Together, these data imply that the increase in quantal content under baseline conditions induced by presynaptic <italic>thin</italic> manipulations is separable from a decrease in miniature amplitude. By definition, PHP is induced by a relative decrease in miniature amplitude. Given that quantal content increased after presynaptic <italic>thin</italic> manipulations independent of changes in miniature amplitude, we consider it unlikely that the increased quantal content under baseline conditions represents a homeostatic response. Could the increase in release after presynaptic <italic>thin</italic> perturbation simply occlude PHP? The relative increase in release during PHP of WT synapses exceeds the increase in release under baseline conditions in <italic>thin</italic> mutants. Thus, although we cannot exclude that PHP is solely occluded by enhanced baseline release in <italic>thin</italic> mutants, we consider this scenario unlikely.</p><p>PHP is blocked by acute pharmacological, or prolonged genetic proteasome perturbation at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). Moreover, PHP at this synapse requires <italic>dysbindin</italic> (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>), and genetic data suggest UPS-dependent control of a Dysbindin-sensitive vesicle pool during PHP (<xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>). Based on our finding that <italic>thin</italic> is required for acute and sustained PHP expression (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), and the links between <italic>thin</italic> und <italic>dysbindin</italic> in the context of release modulation outlined above, we propose a model in which Thin-dependent ubiquitination of Dysbindin is decreased during PHP. Given the positive correlation between Dysbindin levels and release (<xref ref-type="bibr" rid="bib15">Dickman et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">Wentzel et al., 2018</xref>), the resulting increase in Dysbindin abundance would potentiate release. Further work is needed to test how Thin is regulated during PHP. Thin is the first E3 ubiquitin ligase linked to homeostatic regulation of neurotransmitter release. Interestingly, a recent study revealed a postsynaptic role for Insomniac, a putative adaptor of the Cullin-3 ubiquitin ligase complex, in PHP at the <italic>Drosophila</italic> NMJ (<xref ref-type="bibr" rid="bib28">Kikuma et al., 2019</xref>), suggesting a key function of the UPS in both synaptic compartments during PHP at this synapse.</p><p>TRIM32, the human ortholog of <italic>thin</italic>, is required for synaptic down-scaling in cultured hippocampal rat neurons (<xref ref-type="bibr" rid="bib61">Srinivasan et al., 2020</xref>), as well as long-term potentiation in hippocampal mouse brain slices (<xref ref-type="bibr" rid="bib43">Ntim et al., 2020</xref>), implying a broader role of this E3 ubiquitin ligase in synaptic plasticity. TRIM32 has been implicated in various neurological disorders, such as depression (<xref ref-type="bibr" rid="bib56">Ruan et al., 2014</xref>), Alzheimer’s disease (<xref ref-type="bibr" rid="bib72">Yokota et al., 2006</xref>), autism spectrum disorder (<xref ref-type="bibr" rid="bib36">Lionel et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Ruan et al., 2014</xref>), or attention deficit hyperactivity disorder (<xref ref-type="bibr" rid="bib35">Lionel et al., 2011</xref>). It will be exciting to explore potential links between TRIM32-dependent control of synaptic homeostasis and these disorders in the future.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>thin<sup>ΔA</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-abba</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-mCherry-thin</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Stock is available upon request</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>GluRIIA<sup>SP16</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Petersen et al., 1997</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>dysbindin<sup>1</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-thin<sup>RNAi</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Perkins et al., 2015</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_42826">BDSC_42826</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-mCherry<sup>RNAi</sup></italic> (P{VALIUM20-mCherry}attP2)</td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_35785">BDSC_35785</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-venus-dysbindin</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>elav<sup>c155</sup>-Gal4</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_458">BDSC_458</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="char" char="hyphen" valign="bottom"><italic>24B-Gal4</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_1767">BDSC_1767</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Bruchpilot (nc82) (mouse monoclonal)</td><td align="left" valign="bottom">DSHB, University of Iowa, USA</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2314866">AB_2314866</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Thermo Fisher Scientific Cat# G10362, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2536526">AB_2536526</ext-link></td><td align="left" valign="bottom">IF: (1:500)<break/>WB: (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (mouse mono clonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Thermo Fisher Scientific Cat# A-11120, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221568">AB_221568</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-DsRed (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Santa Cruz Biotechnology Cat# sc-390909, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2801575">AB_2801575</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-SYNORF1 (Synapsin, 3C11) (mouse monoclonal)</td><td align="left" valign="bottom">DSHB, University of Iowa, USA</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528479">AB_528479</ext-link></td><td align="char" char="." valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Thin (guinea pig polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Larva: (1:200)<break/>S2:<break/>(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-HRP Alexa-Fluor 647 (goat polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch Labs</td><td align="left" valign="bottom">Jackson ImmunoResearch Labs Cat# 123-605-021, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338967">AB_2338967</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HA (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">BioLegend Cat# 901533, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2801249">AB_2801249</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BetaTubulin (mouse monoclonal)</td><td align="left" valign="bottom">DSHB, University of Iowa, USA</td><td align="left" valign="bottom">DSHB Cat# E7, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528499">AB_528499</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Mouse-IgG-H-L-Secondary-Antibody-Polyclonal/31430">Goat anti-Mouse IgG (H</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Mouse-IgG-H-L-Secondary-Antibody-Polyclonal/31430">+</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Mouse-IgG-H-L-Secondary-Antibody-Polyclonal/31430">L</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Mouse-IgG-H-L-Secondary-Antibody-Polyclonal/31430">) Secondary Antibody, HRP</ext-link> (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Thermo Fisher Scientific Cat# 31430, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_228307">AB_228307</ext-link></td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Rabbit-IgG-H-L-Secondary-Antibody-Polyclonal/32460">Goat anti-Rabbit IgG (H</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Rabbit-IgG-H-L-Secondary-Antibody-Polyclonal/32460">+</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Rabbit-IgG-H-L-Secondary-Antibody-Polyclonal/32460">L</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/Goat-anti-Rabbit-IgG-H-L-Secondary-Antibody-Polyclonal/32460">) Secondary Antibody, HRP</ext-link> (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Thermo Fisher Scientific Cat# 32460, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1185567">AB_1185567</ext-link></td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa-Fluor anti-mouse 488 (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Thermo Fisher Scientific Cat# A32723, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2633275">AB_2633275</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor anti-guinea pig 555<break/>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Thermo Fisher Scientific Cat# A-21435 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535856">AB_2535856</ext-link></td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Atto 594 conjugated anti-mouse (goat polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Sigma-Aldrich Cat# 76,085</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Abberior STAR 635P (goat polyclonal)</td><td align="left" valign="bottom">Abberior</td><td align="left" valign="bottom">Abberior Cat# ST635P-1002-500 UG, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2893229">AB_2893229</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bouin’s fixative</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">HT-10132</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ethanol</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">CAS# 64-17-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ProLong Gold Antifade</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">P36930</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Philanthotoxin-433</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-255421</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Schneider’s <italic>Drosophila</italic> medium</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat# 21720024</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FuGENE HD</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# E2311</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">HT501128</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NP-40</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">85,125</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Deoxycholate</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D6750</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">cOmplete</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="char" char="." valign="bottom">11697498001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ECL Prime Western Blotting Detection Reagent</td><td align="left" valign="bottom">GE Healthcare</td><td align="left" valign="bottom">Cat# 28980926</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Drosophila</italic> Schneider 2 (S2) Cells</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# R69007</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Nitrocellulose membrane</td><td align="left" valign="bottom">Amersham Hibond GE Healthcare</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/order/catalog/product/88018">Cat#</ext-link> 88,018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMT-Gal4</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_53366">Addgene_53366</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji / ImageJ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://fiji.sc">https://fiji.sc</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="bottom">Version 1.51n</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Clampex</td><td align="left" valign="bottom">Axon CNS, Molecular Devices</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011323">SCR_011323</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Leica Application Suite X</td><td align="left" valign="bottom">Leica Microsystems</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013673">SCR_013673</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Huygens Software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://svi.nl/HuygensSoftware">https://svi.nl/HuygensSoftware</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014237">SCR_014237</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Igor Pro</td><td align="left" valign="bottom">WaveMetrics</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000325">SCR_000325</ext-link></td><td align="left" valign="bottom">Version 6.37</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">NeuroMatic</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Rothman and Silver, 2018</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_004186">SCR_004186</ext-link></td><td align="left" valign="bottom">Version 3.0c</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">NumPy</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.numpy.org">https://www.numpy.org</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008633">SCR_008633</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SciPy</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.scipy.org">https://www.scipy.org</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008058">SCR_008058</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">IPython</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://ipython.org">http://ipython.org</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001658">SCR_001658</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Neo</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://neuralensemble.org/neo">http://neuralensemble.org/neo</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000634">SCR_000634</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Shapely</td><td align="left" valign="bottom">(<xref ref-type="bibr" rid="bib22">Gillies, 2007</xref>) <ext-link ext-link-type="uri" xlink:href="https://github.com/shapely/shapely">https://github.com/shapely/shapely</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">(<xref ref-type="bibr" rid="bib53">R Studio Team, 2020</xref>)<break/><break/><ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/">http://www.rstudio.com/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000432">SCR_000432</ext-link></td><td align="left" valign="bottom">Version 2021.09.0</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pwr-package</td><td align="left" valign="bottom">(<xref ref-type="bibr" rid="bib3">Champely, 2020</xref>)<break/><break/><ext-link ext-link-type="uri" xlink:href="https://github.com/heliosdrm/pwr">https://github.com/heliosdrm/pwr</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GNU Image Manipulation Program</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.gimp.org/">https://www.gimp.org/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003182">SCR_003182</ext-link></td><td align="left" valign="bottom">Version 2.8.10</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Inkscape</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.inkscape.org">http://www.inkscape.org</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014479">SCR_014479</ext-link></td><td align="left" valign="bottom">Version 0.92.2</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Affinity Designer</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://affinity.serif.com/en-us/designer/">https://affinity.serif.com/en-us/designer/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016952">SCR_016952</ext-link></td><td align="left" valign="bottom">Version 1.10.4</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Fly stocks and genetics</title><p><italic>Drosophila</italic> stocks were maintained at 21–25°C on normal food. The <italic>w<sup>1118</sup></italic> strain was used as the WT control. <italic>GluRIIA<sup>SP16</sup></italic> mutants (<xref ref-type="bibr" rid="bib50">Petersen et al., 1997</xref>) and <italic>dysbindin<sup>1</sup></italic> mutants (<xref ref-type="bibr" rid="bib14">Dickman and Davis, 2009</xref>) were a kind gift from Graeme Davis’ lab. <italic>thin<sup>ΔA</sup></italic> mutants and <italic>UAS-abba</italic> transgenic flies, now referred to as <italic>UAS-thin</italic> (<xref ref-type="bibr" rid="bib32">LaBeau-DiMenna et al., 2012</xref>), were a generous gift from Erika Geisbrecht. The <italic>UAS-thin<sup>RNAi</sup></italic> stock (BDSC stock 42826, <xref ref-type="bibr" rid="bib48">Perkins et al., 2015</xref>) and the <italic>UAS-mCherry<sup>RNAi</sup></italic> stock (BDSC stock 35785) were obtained from the Bloomington <italic>Drosophila</italic> Stock Center (BDSC, Bloomington, IN, USA), and the <italic>UAS-venus-dysbindin</italic> line was provided by Dion Dickman’s lab. For pan-neuronal expression, the <italic>elav<sup>c155</sup>-Gal4</italic> (on the X chromosome) driver line was used and analysis was restricted to male larvae. For expression in muscle cells, we used the <italic>24B-Gal4</italic> driver line. Both driver lines were obtained from the BDSC. Standard second and third chromosome balancer lines (BDSC) and genetic strategies were used for all crosses and for maintaining the mutant lines. For the generation of transgenic flies carrying <italic>UAS-mCherry-thin</italic>, constructs based on the pUAST-attB vector backbone were injected into the ZP-attP-86Fb fly line harboring a landing site on the third chromosome according to standard procedures (<xref ref-type="bibr" rid="bib1">Bischof et al., 2014</xref>).</p></sec><sec id="s4-2"><title>Cell culture and transfection</title><p>Schneider S2 cells were obtained from Thermo Fisher Scientific (‘Gibco <italic>Drosophila</italic> S2 cells’; Cat# R69007). The supplier’s Master Seed Bank was characterized by isozyme and karyotype analysis, and was tested for contamination of bacteria, yeast, mycoplasma, and virus. We have not independently verified cell line identity or tested for mycoplasma contamination. However, contamination with other cell lines is unlikely, because the used cell line is (1) the only cell line used in the lab, (2) the only <italic>Drosophila</italic> cell line present at the institute, and (3) cells grow at 25° and in a different medium compared to human cell lines. Cells were used within 10 months after purchase. Schneider S2 cells were cultivated in standard Schneider’s <italic>Drosophila</italic> medium (Gibco) containing 10% fetal calf serum and 5% penicilin/streptomycin at 25°C. For immunohistochemistry and microscopy, cells were plated on cover slips in 12-well plates with 80% density and transfected with 1.5 μg (total) vector DNA using FuGENE HD Transfection Reagent according to the standard protocol. The following vectors were used: pMT-Gal4 (Addgene), pUAS-mCherry-thin, pUAS-HA-thin, pUAS-venus-dysbindin (Dion Dickman), and empty pUAS to adjust to equal DNA levels. Twenty-four hours after plating, CuSO<sub>4</sub> (0.5 mM) was added to the culture for 24 hr to induce the expression of the pMT vector driving Gal4, which in turn drives transcription of UAS constructs.</p></sec><sec id="s4-3"><title>Plasmid construction</title><p>For the pUAS-mCherry-thin vector, mCherry was cloned into pUAS-attB (Addgene) via EcoRI/NotI using the following primers:</p><p>(fw: <named-content content-type="sequence">5′-GCGAATTCATGGTGAGCAAGGGCGAGGAG-3′</named-content>, rev: <named-content content-type="sequence">5′- GCGCGGCCGCCCTTGTACAGCTCGTCCATGCCG-3′</named-content>).</p><p>Thin isoform A (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_137546.3">NM_137546.3</ext-link>) was amplified from <italic>Drosophila</italic> cDNA by PCR using the following primers:</p><p>(fw: <named-content content-type="sequence">5′-CGGCGGCCGCATGGAGCAATTCGAGCAGCTGT-3′</named-content>, rev: <named-content content-type="sequence">5′-CGTCTAGAATGAAGACTTGGACGCGGTGATTCTCTCG-3′</named-content>) and then cloned into the pUAS-mCherry vector via NotI/XbaI.</p><p>pUAS-HA-thin was generated by In-Fusion mutagenesis (TaKaRa) from the pUAS-mCherry-thin plasmid with the following primers:</p><p>(fw: <named-content content-type="sequence">5′-AGATTACGCTTATCCATATGATGTTCCAGATTATGCTGGCCGCATGGAGCAATTC-3′</named-content> and rev: <named-content content-type="sequence">5′-GGATAAGCGTAATCTGGAACATCGTATGGGTACATAATTCCCAATTCCCTATTCAGAGT-3′</named-content>).</p><p>Correct cloning was confirmed by sequencing on all final vectors.</p></sec><sec id="s4-4"><title>Electrophysiology</title><p>Electrophysiological recordings were made from third-instar larvae at the wandering stage. Larvae were dissected and sharp-electrode recordings were made from muscle 6 in abdominal segments 3 and 4 using an Axoclamp 900 A amplifier (Molecular Devices). The extracellular HL3 saline contained (in mM): 70 NaCl, 5 KCl, 10 MgCl<sub>2</sub>, 10 Na-HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 115 sucrose, 5 trehalose, 5 HEPES, 1.5 CaCl<sub>2</sub>. To induce PHP, larvae were incubated with 20 μM PhTX-433 (Santa Cruz Biotechnology) for 10 min at room temperature after partial dissection (see <xref ref-type="bibr" rid="bib19">Frank et al., 2006</xref>). AP-evoked EPSCs were induced by stimulating hemi-segmental nerves with single APs (0.3-ms stimulus duration, 0.3 Hz), and recorded with a combination of a HS-9A × 10 and a HS-9A × 0.1 headstage (Molecular Devices) in two-electrode voltage clamp mode. mEPSPs and mEPSCs were recorded with one or two HS-9A × 0.1 headstage(s) (Molecular Devices), respectively. Muscle cells were clamped to a membrane potential of −65 mV for EPSC and −100 mV for mEPSC recordings to increase the signal-to-noise ratio.</p><p>A total of 50 EPSCs were averaged to obtain the mean EPSC amplitude for each NMJ. mEPSCs and EPSCs were recorded in different NMJs because different headstage combinations were used to improve the signal-to-noise-ratio for mEPSC recordings. Hence, quantal content was calculated by dividing the mean EPSC amplitude of each NMJ by the average of the average mEPSC amplitude of all NMJs of a given experimental group. RRP size was estimated by the method of cumulative EPSC amplitudes (<xref ref-type="bibr" rid="bib58">Schneggenburger et al., 1999</xref>). NMJs were stimulated with 60 Hz trains (60 stimuli, 5 trains per cell), and the cumulative EPSC amplitude was obtained by back-extrapolating a linear fit to the last 15 cumulative EPSC amplitude values of the 60 Hz train to time zero. The cumulative EPSC amplitude of each NMJ was then divided by the average mEPSC amplitude of all NMJs of a given experimental group to obtain the RRP estimate.</p></sec><sec id="s4-5"><title>Immunohistochemistry and microscopy</title><sec id="s4-5-1"><title><italic>Drosophila</italic> NMJ</title><p>Third-instar larval preparations were fixed for 3 min with Bouin’s fixative (100%, Sigma-Aldrich) for confocal microscopy, or ice-cold ethanol (100%, Merck) for 10 min for confocal/STED microscopy. Preparations were washed thoroughly with phosphate-buffered saline (PBS) containing 0.1% Triton X-100 (PBST). After washing, preparations were blocked with 3% normal goat serum in PBST. Incubation with the primary antibody was done at 4°C on a rotating platform overnight. The following antibodies and dilutions were used for NMJ stainings: (<italic>Primary</italic>) anti-Bruchpilot (nc82, mouse, DSHB, 1:100), anti-GFP (rabbit, Thermo Fisher Scientific, 1:500), anti-GFP (mouse, Thermo Fisher Scientific, 1:500), anti-DsRed (mouse, Santa Cruz Biotechnology, 1:500), anti-SYNORF1 (Synapsin, 3C11, mouse, DSHB, 1:250), anti-Thin (guinea pig, gift from Erika R. Geisbrecht, 1:200), and anti-HRP Alexa-Fluor 647 (goat, Jackson ImmunoResearch, 1:200). For confocal microscopy, Alexa-Fluor anti-mouse 488 (Thermo Fisher Scientific; 1:500) and Alexa Fluor anti-guinea pig 555 (Thermo Fisher Scientific; 1:400) were applied overnight at 4°C on a rotating platform. For gSTED microscopy, the following secondary antibodies (1:100) were applied for 2 hr at room temperature (RT) on a rotating platform: Atto 594 (anti-mouse, Sigma-Aldrich) and Abberior STAR 635P (anti-rabbit, Abberior). Experimental groups of a given experiment were processed in parallel in the same tube. Preparations were mounted onto slides with ProLong Gold (Thermo Fisher Scientific).</p></sec><sec id="s4-5-2"><title>S2 cell culture</title><p>S2 cells grown on coverslips were washed with PBST and fixed with 10% PFA (paraformaldehyde) for 10 min. After washing three times with PBST, preparations were blocked with 5% normal goat serum in PBST for 30 min. Incubation with primary antibodies was done at RT on a rotating platform for 2 hr. The following antibodies were used for S2 cell stainings: anti-thin (guinea pig, gift from Erika R. Geisbrecht, 1:400), anti-Dysbindin (mouse, gift from Dion Dickman, 1:400). After washing three times with PBST, cells were incubated with the secondary antibodies Alexa Fluor anti-guinea pig 555 and Alexa Fluor anti-mouse 488 (Thermo Fisher Scientific; both 1:400) at RT on a rotating platform for 2 hr. Cover slips were mounted onto slides with ProLong Gold (Thermo Fisher Scientific) after three PBST washes.</p></sec><sec id="s4-5-3"><title>Confocal and gSTED microscopy</title><p>Images were acquired with an inverse Leica TCS SP8 STED 3× microscope (Leica Microsystems, Germany) of the University of Zurich Center for Microscopy and Image Analysis. Excitation light (580 or 640 nm) of a flexible white light laser was focused onto the specimen using a 100× objective (HC PL APO 1.40 NA Oil STED WHITE; Leica Microsystems, Germany) with immersion oil conforming to ISO 8036 with a diffraction index of <italic>n</italic> = 1.5180 (Leica Microsystems, Germany). For gSTED imaging, the flexible white light laser was combined with a 775 nm STED depletion laser. Emitted light was detected with two HyD detectors in photon counting mode (Leica Microsystems, Germany). Pixel size was 20 × 20 nm and z-stacks were acquired with a step size of 120 nm. For STED imaging, we used time-gated single photon detection (empirical adjustment within a fluorescence lifetime interval from 0.7 to 6.0 ns). Line accumulation was set to 1 and 6 for confocal and STED imaging, respectively. Images were acquired with Leica Application Suite X software (Leica Application Suite X, version 2.0; Leica Microsystems, Germany). Experimental groups were imaged side-by-side with identical settings.</p><p>Images were processed and deconvolved with Huygens Professional (Huygens compute engine 17.04, Scientific Volume Imaging B.V., Netherlands). In brief, the ‘automatic background detection’ tool (radius = 0.7 µm), and the ‘auto stabilize’ feature were used to correct for background and lateral drift. Images were deconvolved using the Good’s roughness Maximum Likelihood algorithm with default parameter settings (maximum iterations: 10; signal-to-noise ratio: 7 for STED and 15 for confocal; quality threshold: 0.003).</p></sec></sec><sec id="s4-6"><title>Western blot</title><p>Transfected cells in 12-well plates were harvested after 72 hr, washed with PBS and lysed by adding 50 µl of RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 0.4 mM EDTA (ethylenediaminetetraacetic acid), 10% glycerol) containing protease inhibitors (cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail, Sigma-Aldrich) for 30 min on ice. The lysates were sonified three times for 1 min and boiled for 5 min in SDS-sample buffer containing 5% β-mercaptoethanol. Samples were separated on acrylamide gels using SDS–polyacrylamide gel electrophoresis (PAGE), then transferred to nitrocellulose membranes (Amersham Hibond GE Healthcare). After blocking in 5% milk in PBST for 1 hr, membranes were incubated in the following primary antibodies: anti-GFP (rabbit, Thermo Fisher Scientific, 1:1000), anti-HA (mouse, Biolegend, 1:1000), and anti-Tubulin (E7, mouse, DSHB, 1:1000) in blocking solution overnight. Horseradish peroxidase-conjugated secondary antibodies (anti-mouse-HRP and anti-rabbit-HRP, 1:2000 in blocking solution) were applied to membranes for 2 hr. Detection was performed using ECL Reagent (GE Healthcare, Chicago, IL, USA). Western blots were revealed using enhanced chemiluminescence and imaged using a Fusion FX7 system (Vilber Lourmat). Densitometric analyses (mean pixel intensity of a ROI containing a band of interest) were done in Fiji/ImageJ.</p></sec><sec id="s4-7"><title>Data analysis</title><sec id="s4-7-1"><title>Electrophysiology</title><p>Electrophysiology data were acquired with Clampex (Axon CNS, Molecular Devices) and analyzed with custom-written routines in Igor Pro (Wavemetrics). For the genetic screen data, mEPSPs were detected with a template matching algorithm implemented in Neuromatic (Rothman &amp; Silver, 2018) running in Igor Pro (Wavemetrics). The average mEPSP amplitude was calculated from all detected events in a recording after visual inspection for false positives. For the remaining data, mEPSC data were analyzed using routines written with scientific python libraries, including numpy, scipy, IPython and neo (<xref ref-type="bibr" rid="bib20">Garcia et al., 2014</xref>), and mEPSCs were detected using an implementation of a template-matching algorithm (<xref ref-type="bibr" rid="bib7">Clements and Bekkers, 1997</xref>).</p></sec><sec id="s4-7-2"><title>NMJ morphology</title><p>Microscopy images were analyzed using custom-written routines in ImageJ/Fiji (version 1.51n, National Institutes of Health, USA). Brp quantification was performed as follows: First, individual Brp puncta were isolated by segmenting binary fluorescence intensity threshold masks (15% or 35% of the maximum intensity value) of background corrected (rolling ball, radius = 1 μm) and filtered (3 × 3 median) maximum intensity projection images. The number of Brp objects in the mask served as a proxy for AZ number and was normalized to the area of the HRP mask (binary mask, 15% or 35% of the maximum intensity value). Average Brp-intensity values were calculated for each Brp punctum from background-corrected, unfiltered maximum intensity projection images.</p></sec><sec id="s4-7-3"><title>NND analysis</title><p>For the NND analysis (<xref ref-type="fig" rid="fig5">Figure 5</xref>), individual synaptic boutons were segmented manually within a deconvolved gSTED stack and a single plane in the middle of the bouton was extracted for further analysis. Next, Fiji’s ‘Find Maxima’ algorithm was used to obtain the <italic>x</italic>,<italic>y</italic> coordinate of the brightest pixel within each Dysbindin<sup>venus</sup> and Thin<sup>mCherry</sup> punctum. For the maximum of each Dysbindin punctum, the distances to the maxima of all Thin puncta within the same bouton were measured and the NNDs were calculated. For each bouton, the analysis was repeated after assigning random <italic>x</italic>,<italic>y</italic> coordinates to each Dysbindin and Thin punctum within the bouton boundaries using the Python package Shapely (Gillies and others, 2007; <ext-link ext-link-type="uri" xlink:href="https://github.com/shapely/shapely">https://github.com/shapely/shapely</ext-link>). NND values were averaged for each bouton.</p></sec><sec id="s4-7-4"><title>Correlation analysis S2 cells</title><p>Pearson’s correlation coefficients (<italic>r</italic>) were calculated for each pixel in single confocal planes of <italic>Drosophila</italic> S2 cells coexpressing Dysbindin<sup>venus</sup> and Thin<sup>mCherry</sup> using Costes’ approach (<xref ref-type="bibr" rid="bib9">Costes et al., 2004</xref>) implemented in the JACoP toolbox of ImageJ/Fiji (<xref ref-type="bibr" rid="bib2">Bolte and Cordelières, 2006</xref>; <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>). The algorithm also creates simulated images by randomly sampling point spread function-sized chunks of the original image, and calculating <italic>r</italic> for each pixel of the simulated data.</p></sec><sec id="s4-7-5"><title>Statistics</title><p>Statistical analyses were done using RStudio Team (2021). RStudio: Integrated Development Environment for R. RStudio, PBC, Boston, MA, <ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/">http://www.rstudio.com/</ext-link>. For more than two factors, we used two-way analysis of variance (ANOVA) followed by Tukey’s post hoc test to correct for multiple comparisons between genotypes and conditions. For one factor with more than two groups, one-way ANOVA with Tukey’s multiple comparisons was performed. Two-sided Student’s <italic>t</italic>-tests or nonparametric Mann–Whitney <italic>U</italic>-tests were used for comparison between two groups after a Shapiro–Wilk test and a Levene’s test. Statistical significance (p) was set to 0.05 (*), 0.01 (**), and 0.001 (***). Power analysis was performed using the pwr-package of Rstudio. Minimum desired effect size based on Cohen’s d value was used to estimate the minimum sample size for a power ≥0.8 and a significance level of 0.05 for two-sided Student’s <italic>t</italic>-tests or Mann–Whitney <italic>U</italic>-tests. Data are given as mean ± standard error of the mean (SEM).</p><p>Figures were assembled using GIMP (The GIMP team, 2.8.10, <ext-link ext-link-type="uri" xlink:href="https://www.gimp.org/">https://www.gimp.org/</ext-link>), Inkscape (Inkscape project, 0.92.2. <ext-link ext-link-type="uri" xlink:href="http://www.inkscape.org">http://www.inkscape.org</ext-link>), and Affinity Designer (1.10.4, Serif (Europe) Ltd, West Bridgford, Nottinghamshire, United Kingdom).</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Software, Formal analysis, Investigation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-71437-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Summary table of electrophysiology data for the genetic screen.</title><p>Data are mean ± SEM. UAS-RNAis were driven in neurons by elavc155-Gal4, and elavc155-Gal4/Y served as the control. We tested 157 putative E3 ligase-encoding genes and 11 E3-associated genes, using 180 lines (UAS-RNAi or mutants; some genes were targeted with multiple lines; mean <italic>n</italic> = 4 NMJs per line, range 3–12 per line). Control data were continuously collected throughout the genetic screen. See Materials and methods for further details.</p></caption><media xlink:href="elife-71437-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1-6.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful to the members of the Müller lab for helpful discussions and critical comments on the manuscript. We thank Dr. Damian Szklarczyk for help with STRING-based protein–protein interaction analysis used for prioritization of E3 ligases, and Dr. Marian Hruska-Plochan for help with the western blot analysis. Stocks obtained from the Bloomington <italic>Drosophila</italic> Stock Center (NIH P40OD018537) were used in this study.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischof</surname><given-names>J</given-names></name><name><surname>Sheils</surname><given-names>EM</given-names></name><name><surname>Björklund</surname><given-names>M</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Generation of a transgenic ORFeome library in <italic>Drosophila</italic></article-title><source>Nature Protocols</source><volume>9</volume><fpage>1607</fpage><lpage>1620</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.105</pub-id><pub-id pub-id-type="pmid">24922270</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolte</surname><given-names>S</given-names></name><name><surname>Cordelières</surname><given-names>FP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A guided tour into subcellular colocalization analysis in light microscopy</article-title><source>Journal of Microscopy</source><volume>224</volume><fpage>213</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2818.2006.01706.x</pub-id><pub-id pub-id-type="pmid">17210054</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Champely</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>pwr: Basic Functions for Power Analysis</data-title><version designator="1.3-0">1.3-0</version><publisher-name>R package</publisher-name><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=pwr">https://CRAN.R-project.org/package=pwr</ext-link></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Richlitzki</surname><given-names>A</given-names></name><name><surname>Featherstone</surname><given-names>DE</given-names></name><name><surname>Schwärzel</surname><given-names>M</given-names></name><name><surname>Richmond</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tomosyn-dependent regulation of synaptic transmission is required for a late phase of associative odor memory</article-title><source>PNAS</source><volume>108</volume><fpage>18482</fpage><lpage>18487</lpage><pub-id pub-id-type="doi">10.1073/pnas.1110184108</pub-id><pub-id pub-id-type="pmid">22042858</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chintapalli</surname><given-names>VR</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dow</surname><given-names>JAT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Using FlyAtlas to identify better <italic>Drosophila melanogaster</italic> models of human disease</article-title><source>Nature Genetics</source><volume>39</volume><fpage>715</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1038/ng2049</pub-id><pub-id pub-id-type="pmid">17534367</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cijsouw</surname><given-names>T</given-names></name><name><surname>Ramsey</surname><given-names>AM</given-names></name><name><surname>Lam</surname><given-names>TT</given-names></name><name><surname>Carbone</surname><given-names>BE</given-names></name><name><surname>Blanpied</surname><given-names>TA</given-names></name><name><surname>Biederer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mapping the proteome of the synaptic cleft through proximity labeling reveals new cleft proteins</article-title><source>Proteomes</source><volume>6</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.3390/proteomes6040048</pub-id><pub-id pub-id-type="pmid">30487426</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clements</surname><given-names>JD</given-names></name><name><surname>Bekkers</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Detection of spontaneous synaptic events with an optimally scaled template</article-title><source>Biophysical Journal</source><volume>73</volume><fpage>220</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(97)78062-7</pub-id><pub-id pub-id-type="pmid">9199786</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>LD</given-names></name><name><surname>Zuchman</surname><given-names>R</given-names></name><name><surname>Sorokina</surname><given-names>O</given-names></name><name><surname>Müller</surname><given-names>A</given-names></name><name><surname>Dieterich</surname><given-names>DC</given-names></name><name><surname>Armstrong</surname><given-names>JD</given-names></name><name><surname>Ziv</surname><given-names>T</given-names></name><name><surname>Ziv</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabolic turnover of synaptic proteins: kinetics, interdependencies and implications for synaptic maintenance</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e63191</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0063191</pub-id><pub-id pub-id-type="pmid">23658807</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costes</surname><given-names>SV</given-names></name><name><surname>Daelemans</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>EH</given-names></name><name><surname>Dobbin</surname><given-names>Z</given-names></name><name><surname>Pavlakis</surname><given-names>G</given-names></name><name><surname>Lockett</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Automatic and quantitative measurement of protein-protein colocalization in live cells</article-title><source>Biophysical Journal</source><volume>86</volume><fpage>3993</fpage><lpage>4003</lpage><pub-id pub-id-type="doi">10.1529/biophysj.103.038422</pub-id><pub-id pub-id-type="pmid">15189895</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cull-Candy</surname><given-names>SG</given-names></name><name><surname>Miledi</surname><given-names>R</given-names></name><name><surname>Trautmann</surname><given-names>A</given-names></name><name><surname>Uchitel</surname><given-names>OD</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates</article-title><source>The Journal of Physiology</source><volume>299</volume><fpage>621</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1980.sp013145</pub-id><pub-id pub-id-type="pmid">6103954</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvendahl</surname><given-names>I</given-names></name><name><surname>Kita</surname><given-names>K</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Rapid and sustained homeostatic control of presynaptic exocytosis at a central synapse</article-title><source>PNAS</source><volume>116</volume><fpage>23783</fpage><lpage>23789</lpage><pub-id pub-id-type="doi">10.1073/pnas.1909675116</pub-id><pub-id pub-id-type="pmid">31685637</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvendahl</surname><given-names>I</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Homeostatic plasticity-a presynaptic perspective</article-title><source>Current Opinion in Neurobiology</source><volume>54</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.10.003</pub-id><pub-id pub-id-type="pmid">30384022</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Haghighi</surname><given-names>AP</given-names></name><name><surname>Portman</surname><given-names>SL</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Amaranto</surname><given-names>AM</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Ubiquitination-dependent mechanisms regulate synaptic growth and function</article-title><source>Nature</source><volume>412</volume><fpage>449</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/35086595</pub-id><pub-id pub-id-type="pmid">11473321</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickman</surname><given-names>DK</given-names></name><name><surname>Davis</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis</article-title><source>Science</source><volume>326</volume><fpage>1127</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1126/science.1179685</pub-id><pub-id pub-id-type="pmid">19965435</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickman</surname><given-names>DK</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Snapin is critical for presynaptic homeostatic plasticity</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>8716</fpage><lpage>8724</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5465-11.2012</pub-id><pub-id pub-id-type="pmid">22723711</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domsch</surname><given-names>K</given-names></name><name><surname>Ezzeddine</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Abba is an essential TRIM/RBCC protein to maintain the integrity of sarcomeric cytoarchitecture</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>3314</fpage><lpage>3323</lpage><pub-id pub-id-type="doi">10.1242/jcs.122366</pub-id><pub-id pub-id-type="pmid">23729735</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Ospina</surname><given-names>JK</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>In vivo RNAi screen reveals neddylation genes as novel regulators of Hedgehog signaling</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e24168</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0024168</pub-id><pub-id pub-id-type="pmid">21931660</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornasiero</surname><given-names>EF</given-names></name><name><surname>Mandad</surname><given-names>S</given-names></name><name><surname>Wildhagen</surname><given-names>H</given-names></name><name><surname>Alevra</surname><given-names>M</given-names></name><name><surname>Rammner</surname><given-names>B</given-names></name><name><surname>Keihani</surname><given-names>S</given-names></name><name><surname>Opazo</surname><given-names>F</given-names></name><name><surname>Urban</surname><given-names>I</given-names></name><name><surname>Ischebeck</surname><given-names>T</given-names></name><name><surname>Sakib</surname><given-names>MS</given-names></name><name><surname>Fard</surname><given-names>MK</given-names></name><name><surname>Kirli</surname><given-names>K</given-names></name><name><surname>Centeno</surname><given-names>TP</given-names></name><name><surname>Vidal</surname><given-names>RO</given-names></name><name><surname>Rahman</surname><given-names>R-U</given-names></name><name><surname>Benito</surname><given-names>E</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Dennerlein</surname><given-names>S</given-names></name><name><surname>Rehling</surname><given-names>P</given-names></name><name><surname>Feussner</surname><given-names>I</given-names></name><name><surname>Bonn</surname><given-names>S</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Rizzoli</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions</article-title><source>Nature Communications</source><volume>9</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/s41467-018-06519-0</pub-id><pub-id pub-id-type="pmid">30315172</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>CA</given-names></name><name><surname>Kennedy</surname><given-names>MJ</given-names></name><name><surname>Goold</surname><given-names>CP</given-names></name><name><surname>Marek</surname><given-names>KW</given-names></name><name><surname>Davis</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mechanisms underlying the rapid induction and sustained expression of synaptic homeostasis</article-title><source>Neuron</source><volume>52</volume><fpage>663</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.029</pub-id><pub-id pub-id-type="pmid">17114050</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>S</given-names></name><name><surname>Guarino</surname><given-names>D</given-names></name><name><surname>Jaillet</surname><given-names>F</given-names></name><name><surname>Jennings</surname><given-names>T</given-names></name><name><surname>Pröpper</surname><given-names>R</given-names></name><name><surname>Rautenberg</surname><given-names>PL</given-names></name><name><surname>Rodgers</surname><given-names>CC</given-names></name><name><surname>Sobolev</surname><given-names>A</given-names></name><name><surname>Wachtler</surname><given-names>T</given-names></name><name><surname>Yger</surname><given-names>P</given-names></name><name><surname>Davison</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neo: an object model for handling electrophysiology data in multiple formats</article-title><source>Frontiers in Neuroinformatics</source><volume>8</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.3389/fninf.2014.00010</pub-id><pub-id pub-id-type="pmid">24600386</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>AJ</given-names></name><name><surname>Hoffiz</surname><given-names>YC</given-names></name><name><surname>Charles</surname><given-names>AJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Mabb</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A comprehensive atlas of E3 ubiquitin ligase mutations in neurological disorders</article-title><source>Frontiers in Genetics</source><volume>9</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2018.00029</pub-id><pub-id pub-id-type="pmid">29491882</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Gillies</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><data-title>Shapely: manipulation and analysis of geometric objects</data-title><version designator="1.8.2">1.8.2</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/shapely/shapely">https://github.com/shapely/shapely</ext-link></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatsuzawa</surname><given-names>K</given-names></name><name><surname>Lang</surname><given-names>T</given-names></name><name><surname>Fasshauer</surname><given-names>D</given-names></name><name><surname>Bruns</surname><given-names>D</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The R-SNARE motif of tomosyn forms SNARE core complexes with syntaxin 1 and SNAP-25 and down-regulates exocytosis</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>31159</fpage><lpage>31166</lpage><pub-id pub-id-type="doi">10.1074/jbc.M305500200</pub-id><pub-id pub-id-type="pmid">12782620</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The ubiquitin-proteasome pathway and synaptic plasticity</article-title><source>Learning &amp; Memory</source><volume>17</volume><fpage>314</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1101/lm.1504010</pub-id><pub-id pub-id-type="pmid">20566674</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Flockhart</surname><given-names>I</given-names></name><name><surname>Vinayagam</surname><given-names>A</given-names></name><name><surname>Bergwitz</surname><given-names>C</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>An integrative approach to ortholog prediction for disease-focused and other functional studies</article-title><source>BMC Bioinformatics</source><volume>12</volume><fpage>316</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1186/1471-2105-12-357</pub-id><pub-id pub-id-type="pmid">21880147</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jan</surname><given-names>LY</given-names></name><name><surname>Jan</surname><given-names>YN</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Antibodies to horseradish peroxidase as specific neuronal markers in <italic>Drosophila</italic> and in grasshopper embryos</article-title><source>PNAS</source><volume>79</volume><fpage>2700</fpage><lpage>2704</lpage><pub-id pub-id-type="doi">10.1073/pnas.79.8.2700</pub-id><pub-id pub-id-type="pmid">6806816</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ketosugbo</surname><given-names>KF</given-names></name><name><surname>Bushnell</surname><given-names>HL</given-names></name><name><surname>Johnson</surname><given-names>RI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A screen for E3 ubiquitination ligases that genetically interact with the adaptor protein Cindr during <italic>Drosophila</italic> eye patterning</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0187571</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0187571</pub-id><pub-id pub-id-type="pmid">29117266</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuma</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Perry</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Goel</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Stavropoulos</surname><given-names>N</given-names></name><name><surname>Dickman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cul3 and insomniac are required for rapid ubiquitination of postsynaptic targets and retrograde homeostatic signaling</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2998</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10992-6</pub-id><pub-id pub-id-type="pmid">31278365</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittel</surname><given-names>RJ</given-names></name><name><surname>Wichmann</surname><given-names>C</given-names></name><name><surname>Rasse</surname><given-names>TM</given-names></name><name><surname>Fouquet</surname><given-names>W</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Schmid</surname><given-names>A</given-names></name><name><surname>Wagh</surname><given-names>DA</given-names></name><name><surname>Pawlu</surname><given-names>C</given-names></name><name><surname>Kellner</surname><given-names>RR</given-names></name><name><surname>Willig</surname><given-names>KI</given-names></name><name><surname>Hell</surname><given-names>SW</given-names></name><name><surname>Buchner</surname><given-names>E</given-names></name><name><surname>Heckmann</surname><given-names>M</given-names></name><name><surname>Sigrist</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Bruchpilot promotes active zone assembly, Ca2+ channel clustering, and vesicle release</article-title><source>Science</source><volume>312</volume><fpage>1051</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1126/science.1126308</pub-id><pub-id pub-id-type="pmid">16614170</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreko-Pierce</surname><given-names>T</given-names></name><name><surname>Eaton</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The <italic>Drosophila</italic> LC8 homolog cut up specifies the axonal transport of proteasomes</article-title><source>Journal of Cell Science</source><volume>130</volume><fpage>3388</fpage><lpage>3398</lpage><pub-id pub-id-type="doi">10.1242/jcs.207027</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudryashova</surname><given-names>E</given-names></name><name><surname>Kudryashov</surname><given-names>D</given-names></name><name><surname>Kramerova</surname><given-names>I</given-names></name><name><surname>Spencer</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin</article-title><source>Journal of Molecular Biology</source><volume>354</volume><fpage>413</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2005.09.068</pub-id><pub-id pub-id-type="pmid">16243356</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaBeau-DiMenna</surname><given-names>EM</given-names></name><name><surname>Clark</surname><given-names>KA</given-names></name><name><surname>Bauman</surname><given-names>KD</given-names></name><name><surname>Parker</surname><given-names>DS</given-names></name><name><surname>Cripps</surname><given-names>RM</given-names></name><name><surname>Geisbrecht</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Thin, a Trim32 ortholog, is essential for myofibril stability and is required for the integrity of the costamere in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>109</volume><fpage>17983</fpage><lpage>17988</lpage><pub-id pub-id-type="doi">10.1073/pnas.1208408109</pub-id><pub-id pub-id-type="pmid">23071324</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname><given-names>A</given-names></name><name><surname>Marygold</surname><given-names>SJ</given-names></name><name><surname>Antonazzo</surname><given-names>G</given-names></name><name><surname>Attrill</surname><given-names>H</given-names></name><name><surname>dos Santos</surname><given-names>G</given-names></name><name><surname>Garapati</surname><given-names>PV</given-names></name><name><surname>Goodman</surname><given-names>JL</given-names></name><name><surname>Gramates</surname><given-names>LS</given-names></name><name><surname>Millburn</surname><given-names>G</given-names></name><name><surname>Strelets</surname><given-names>VB</given-names></name><name><surname>Tabone</surname><given-names>CJ</given-names></name><name><surname>Thurmond</surname><given-names>J</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Gelbart</surname><given-names>SR</given-names></name><name><surname>Agapite</surname><given-names>J</given-names></name><name><surname>Broll</surname><given-names>K</given-names></name><name><surname>Crosby</surname><given-names>M</given-names></name><name><surname>dos Santos</surname><given-names>G</given-names></name><name><surname>Falls</surname><given-names>K</given-names></name><name><surname>Gramates</surname><given-names>LS</given-names></name><name><surname>Jenkins</surname><given-names>V</given-names></name><name><surname>Longden</surname><given-names>I</given-names></name><name><surname>Matthews</surname><given-names>B</given-names></name><name><surname>Sutherland</surname><given-names>C</given-names></name><name><surname>Tabone</surname><given-names>CJ</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Zytkovicz</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>N</given-names></name><name><surname>Antonazzo</surname><given-names>G</given-names></name><name><surname>Attrill</surname><given-names>H</given-names></name><name><surname>Garapati</surname><given-names>P</given-names></name><name><surname>Larkin</surname><given-names>A</given-names></name><name><surname>Marygold</surname><given-names>S</given-names></name><name><surname>McLachlan</surname><given-names>A</given-names></name><name><surname>Millburn</surname><given-names>G</given-names></name><name><surname>Pilgrim</surname><given-names>C</given-names></name><name><surname>Ozturk-Colak</surname><given-names>A</given-names></name><name><surname>Trovisco</surname><given-names>V</given-names></name><name><surname>Kaufman</surname><given-names>T</given-names></name><name><surname>Calvi</surname><given-names>B</given-names></name><name><surname>Goodman</surname><given-names>J</given-names></name><name><surname>Strelets</surname><given-names>V</given-names></name><name><surname>Thurmond</surname><given-names>J</given-names></name><name><surname>Cripps</surname><given-names>R</given-names></name><name><surname>Lovato</surname><given-names>T</given-names></name><collab>FlyBase Consortium</collab></person-group><year iso-8601-date="2021">2021</year><article-title>FlyBase: updates to the <italic>Drosophila melanogaster</italic> knowledge base</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D899</fpage><lpage>D907</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1026</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Bengtson</surname><given-names>MH</given-names></name><name><surname>Ulbrich</surname><given-names>A</given-names></name><name><surname>Matsuda</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>VA</given-names></name><name><surname>Orth</surname><given-names>A</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name><name><surname>Batalov</surname><given-names>S</given-names></name><name><surname>Joazeiro</surname><given-names>CAP</given-names></name><name><surname>Ploegh</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle’s dynamics and signaling</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e1487</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001487</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionel</surname><given-names>AC</given-names></name><name><surname>Crosbie</surname><given-names>J</given-names></name><name><surname>Barbosa</surname><given-names>N</given-names></name><name><surname>Goodale</surname><given-names>T</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B</given-names></name><name><surname>Rickaby</surname><given-names>J</given-names></name><name><surname>Gazzellone</surname><given-names>M</given-names></name><name><surname>Carson</surname><given-names>AR</given-names></name><name><surname>Howe</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Stewart</surname><given-names>AFR</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Fiebig</surname><given-names>A</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L</given-names></name><name><surname>Fernandez</surname><given-names>BA</given-names></name><name><surname>Roberts</surname><given-names>W</given-names></name><name><surname>Arnold</surname><given-names>PD</given-names></name><name><surname>Szatmari</surname><given-names>P</given-names></name><name><surname>Marshall</surname><given-names>CR</given-names></name><name><surname>Schachar</surname><given-names>R</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD</article-title><source>Science Translational Medicine</source><volume>3</volume><elocation-id>95ra75</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3002464</pub-id><pub-id pub-id-type="pmid">21832240</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionel</surname><given-names>AC</given-names></name><name><surname>Tammimies</surname><given-names>K</given-names></name><name><surname>Vaags</surname><given-names>AK</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Ahn</surname><given-names>JW</given-names></name><name><surname>Merico</surname><given-names>D</given-names></name><name><surname>Noor</surname><given-names>A</given-names></name><name><surname>Runke</surname><given-names>CK</given-names></name><name><surname>Pillalamarri</surname><given-names>VK</given-names></name><name><surname>Carter</surname><given-names>MT</given-names></name><name><surname>Gazzellone</surname><given-names>MJ</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B</given-names></name><name><surname>Fagerberg</surname><given-names>C</given-names></name><name><surname>Laulund</surname><given-names>LW</given-names></name><name><surname>Pellecchia</surname><given-names>G</given-names></name><name><surname>Lamoureux</surname><given-names>S</given-names></name><name><surname>Deshpande</surname><given-names>C</given-names></name><name><surname>Clayton-Smith</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>AC</given-names></name><name><surname>Leather</surname><given-names>S</given-names></name><name><surname>Trounce</surname><given-names>J</given-names></name><name><surname>Melanie Bedford</surname><given-names>H</given-names></name><name><surname>Hatchwell</surname><given-names>E</given-names></name><name><surname>Eis</surname><given-names>PS</given-names></name><name><surname>Yuen</surname><given-names>RKC</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name><name><surname>Uddin</surname><given-names>M</given-names></name><name><surname>Geraghty</surname><given-names>MT</given-names></name><name><surname>Nikkel</surname><given-names>SM</given-names></name><name><surname>Tomiak</surname><given-names>EM</given-names></name><name><surname>Fernandez</surname><given-names>BA</given-names></name><name><surname>Soreni</surname><given-names>N</given-names></name><name><surname>Crosbie</surname><given-names>J</given-names></name><name><surname>Arnold</surname><given-names>PD</given-names></name><name><surname>Schachar</surname><given-names>RJ</given-names></name><name><surname>Roberts</surname><given-names>W</given-names></name><name><surname>Paterson</surname><given-names>AD</given-names></name><name><surname>So</surname><given-names>J</given-names></name><name><surname>Szatmari</surname><given-names>P</given-names></name><name><surname>Chrysler</surname><given-names>C</given-names></name><name><surname>Woodbury-Smith</surname><given-names>M</given-names></name><name><surname>Brian Lowry</surname><given-names>R</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L</given-names></name><name><surname>Mandyam</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Macdonald</surname><given-names>JR</given-names></name><name><surname>Howe</surname><given-names>JL</given-names></name><name><surname>Nalpathamkalam</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tolson</surname><given-names>D</given-names></name><name><surname>Cobb</surname><given-names>DS</given-names></name><name><surname>Wilks</surname><given-names>TM</given-names></name><name><surname>Sorensen</surname><given-names>MJ</given-names></name><name><surname>Bader</surname><given-names>PI</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>B-L</given-names></name><name><surname>Musumeci</surname><given-names>SA</given-names></name><name><surname>Romano</surname><given-names>C</given-names></name><name><surname>Postorivo</surname><given-names>D</given-names></name><name><surname>Nardone</surname><given-names>AM</given-names></name><name><surname>Monica</surname><given-names>MD</given-names></name><name><surname>Scarano</surname><given-names>G</given-names></name><name><surname>Zoccante</surname><given-names>L</given-names></name><name><surname>Novara</surname><given-names>F</given-names></name><name><surname>Zuffardi</surname><given-names>O</given-names></name><name><surname>Ciccone</surname><given-names>R</given-names></name><name><surname>Antona</surname><given-names>V</given-names></name><name><surname>Carella</surname><given-names>M</given-names></name><name><surname>Zelante</surname><given-names>L</given-names></name><name><surname>Cavalli</surname><given-names>P</given-names></name><name><surname>Poggiani</surname><given-names>C</given-names></name><name><surname>Cavallari</surname><given-names>U</given-names></name><name><surname>Argiropoulos</surname><given-names>B</given-names></name><name><surname>Chernos</surname><given-names>J</given-names></name><name><surname>Brasch-Andersen</surname><given-names>C</given-names></name><name><surname>Speevak</surname><given-names>M</given-names></name><name><surname>Fichera</surname><given-names>M</given-names></name><name><surname>Ogilvie</surname><given-names>CM</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Hodge</surname><given-names>JC</given-names></name><name><surname>Talkowski</surname><given-names>ME</given-names></name><name><surname>Stavropoulos</surname><given-names>DJ</given-names></name><name><surname>Marshall</surname><given-names>CR</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes</article-title><source>Human Molecular Genetics</source><volume>23</volume><fpage>2752</fpage><lpage>2768</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt669</pub-id><pub-id pub-id-type="pmid">24381304</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>M</given-names></name><name><surname>Tinsley</surname><given-names>CL</given-names></name><name><surname>Benson</surname><given-names>MA</given-names></name><name><surname>Blake</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TRIM32 is an E3 ubiquitin ligase for dysbindin</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>2344</fpage><lpage>2358</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp167</pub-id><pub-id pub-id-type="pmid">19349376</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marder</surname><given-names>E</given-names></name><name><surname>Goaillard</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Variability, compensation and homeostasis in neuron and network function</article-title><source>Nature Reviews. Neuroscience</source><volume>7</volume><fpage>563</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/nrn1949</pub-id><pub-id pub-id-type="pmid">16791145</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>modENCODE Consortium</collab><name><surname>Celniker</surname><given-names>SE</given-names></name><name><surname>Dillon</surname><given-names>LAL</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Gunsalus</surname><given-names>KC</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name><name><surname>Karpen</surname><given-names>GH</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>EC</given-names></name><name><surname>Lieb</surname><given-names>JD</given-names></name><name><surname>MacAlpine</surname><given-names>DM</given-names></name><name><surname>Micklem</surname><given-names>G</given-names></name><name><surname>Piano</surname><given-names>F</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Stein</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>KP</given-names></name><name><surname>Waterston</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Unlocking the secrets of the genome</article-title><source>Nature</source><volume>459</volume><fpage>927</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1038/459927a</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Pym</surname><given-names>ECG</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rab3-GAP controls the progression of synaptic homeostasis at a late stage of vesicle release</article-title><source>Neuron</source><volume>69</volume><fpage>749</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.025</pub-id><pub-id pub-id-type="pmid">21338884</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>KSY</given-names></name><name><surname>Sigrist</surname><given-names>SJ</given-names></name><name><surname>Davis</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RIM controls homeostatic plasticity through modulation of the readily-releasable vesicle pool</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>16574</fpage><lpage>16585</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0981-12.2012</pub-id><pub-id pub-id-type="pmid">23175813</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>C</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unifying views of autism spectrum disorders: a consideration of autoregulatory feedback loops</article-title><source>Neuron</source><volume>89</volume><fpage>1131</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.017</pub-id><pub-id pub-id-type="pmid">26985722</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntim</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>QF</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>XD</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>HL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Khan</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>XF</given-names></name><name><surname>Walana</surname><given-names>W</given-names></name><name><surname>Khan</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>QH</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TRIM32 deficiency impairs synaptic plasticity by excitatory-inhibitory imbalance via notch pathway</article-title><source>Cerebral Cortex</source><volume>30</volume><fpage>4617</fpage><lpage>4632</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhaa064</pub-id><pub-id pub-id-type="pmid">32219328</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>BO</given-names></name><name><surname>Hauswirth</surname><given-names>AG</given-names></name><name><surname>Celona</surname><given-names>B</given-names></name><name><surname>Fetter</surname><given-names>RD</given-names></name><name><surname>Zunino</surname><given-names>G</given-names></name><name><surname>Kvon</surname><given-names>EZ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Black</surname><given-names>BL</given-names></name><name><surname>Davis</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Presynaptic homeostasis opposes disease progression in mouse models of ALS-like degeneration: evidence for homeostatic neuroprotection</article-title><source>Neuron</source><volume>107</volume><fpage>95</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.04.009</pub-id><pub-id pub-id-type="pmid">32380032</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozato</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Chang</surname><given-names>TH</given-names></name><name><surname>Morse</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TRIM family proteins and their emerging roles in innate immunity</article-title><source>Nature Reviews. Immunology</source><volume>8</volume><fpage>849</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1038/nri2413</pub-id><pub-id pub-id-type="pmid">18836477</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazos Obregón</surname><given-names>F</given-names></name><name><surname>Papalardo</surname><given-names>C</given-names></name><name><surname>Castro</surname><given-names>S</given-names></name><name><surname>Guerberoff</surname><given-names>G</given-names></name><name><surname>Cantera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Putative synaptic genes defined from a <italic>Drosophila</italic> whole body developmental transcriptome by a machine learning approach</article-title><source>BMC Genomics</source><volume>16</volume><elocation-id>694</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-1888-3</pub-id><pub-id pub-id-type="pmid">26370122</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazos Obregón</surname><given-names>F</given-names></name><name><surname>Palazzo</surname><given-names>M</given-names></name><name><surname>Soto</surname><given-names>P</given-names></name><name><surname>Guerberoff</surname><given-names>G</given-names></name><name><surname>Yankilevich</surname><given-names>P</given-names></name><name><surname>Cantera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An improved catalogue of putative synaptic genes defined exclusively by temporal transcription profiles through an ensemble machine learning approach</article-title><source>BMC Genomics</source><volume>20</volume><fpage>1011</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1186/s12864-019-6380-z</pub-id><pub-id pub-id-type="pmid">31870293</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>LA</given-names></name><name><surname>Holderbaum</surname><given-names>L</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Sopko</surname><given-names>R</given-names></name><name><surname>McCall</surname><given-names>K</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Flockhart</surname><given-names>I</given-names></name><name><surname>Binari</surname><given-names>R</given-names></name><name><surname>Shim</surname><given-names>HS</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Housden</surname><given-names>A</given-names></name><name><surname>Foos</surname><given-names>M</given-names></name><name><surname>Randkelv</surname><given-names>S</given-names></name><name><surname>Kelley</surname><given-names>C</given-names></name><name><surname>Namgyal</surname><given-names>P</given-names></name><name><surname>Villalta</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>LP</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Huan-Huan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fujiyama</surname><given-names>A</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Ayers</surname><given-names>K</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Czech</surname><given-names>B</given-names></name><name><surname>Neumuller</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Cavallaro</surname><given-names>A</given-names></name><name><surname>Hibbard</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Cooley</surname><given-names>L</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name><name><surname>Lehmann</surname><given-names>R</given-names></name><name><surname>Parks</surname><given-names>A</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>JQ</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The transgenic RNAi Project at harvard medical school: resources and validation</article-title><source>Genetics</source><volume>201</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.180208</pub-id><pub-id pub-id-type="pmid">26320097</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Dickman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>4153</fpage><lpage>4167</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx304</pub-id><pub-id pub-id-type="pmid">28973139</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>SA</given-names></name><name><surname>Fetter</surname><given-names>RD</given-names></name><name><surname>Noordermeer</surname><given-names>JN</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Genetic analysis of glutamate receptors in <italic>Drosophila</italic> reveals a retrograde signal regulating presynaptic transmitter release</article-title><source>Neuron</source><volume>19</volume><fpage>1237</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80415-8</pub-id><pub-id pub-id-type="pmid">9427247</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilgram</surname><given-names>GSK</given-names></name><name><surname>Potikanond</surname><given-names>S</given-names></name><name><surname>van der Plas</surname><given-names>MC</given-names></name><name><surname>Fradkin</surname><given-names>LG</given-names></name><name><surname>Noordermeer</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The RhoGAP crossveinless-c interacts with Dystrophin and is required for synaptic homeostasis at the <italic>Drosophila</italic> neuromuscular junction</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>492</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4732-10.2011</pub-id><pub-id pub-id-type="pmid">21228159</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plomp</surname><given-names>JJ</given-names></name><name><surname>van Kempen</surname><given-names>GT</given-names></name><name><surname>Molenaar</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats</article-title><source>The Journal of Physiology</source><volume>458</volume><fpage>487</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1992.sp019429</pub-id><pub-id pub-id-type="pmid">1302275</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Studio Team</collab></person-group><year iso-8601-date="2020">2020</year><data-title>RStudio: Integrated Development for R</data-title><version designator="v0.98.1074">v0.98.1074</version><source>Rstudio</source><ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com">http://www.rstudio.com</ext-link></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname><given-names>J</given-names></name><name><surname>Morales</surname><given-names>M</given-names></name><name><surname>Osinalde</surname><given-names>N</given-names></name><name><surname>Martínez-Padrón</surname><given-names>I</given-names></name><name><surname>Mayor</surname><given-names>U</given-names></name><name><surname>Ferrús</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The ubiquitin ligase Ariadne-1 regulates neurotransmitter release via ubiquitination of NSF</article-title><source>Journal of Biological Chemistry</source><volume>296</volume><elocation-id>100408</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.100408</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothman</surname><given-names>JS</given-names></name><name><surname>Silver</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NeuroMatic: an integrated open-source software toolkit for acquisition, analysis and simulation of electrophysiological data</article-title><source>Frontiers in Neuroinformatics</source><volume>12</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.3389/fninf.2018.00014</pub-id><pub-id pub-id-type="pmid">29670519</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>SF</given-names></name><name><surname>Shen</surname><given-names>YJ</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name><name><surname>Zhou</surname><given-names>FH</given-names></name><name><surname>Tan</surname><given-names>LT</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Wang</surname><given-names>WY</given-names></name><name><surname>Xiao</surname><given-names>ZC</given-names></name><name><surname>Zhou</surname><given-names>XF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deletion of TRIM32 protects mice from anxiety- and depression-like behaviors under mild stress</article-title><source>The European Journal of Neuroscience</source><volume>40</volume><fpage>2680</fpage><lpage>2690</lpage><pub-id pub-id-type="doi">10.1111/ejn.12618</pub-id><pub-id pub-id-type="pmid">24839933</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>A</given-names></name><name><surname>Goel</surname><given-names>P</given-names></name><name><surname>Brace</surname><given-names>EJ</given-names></name><name><surname>Buser</surname><given-names>C</given-names></name><name><surname>Dickman</surname><given-names>D</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The E3 ligase Highwire promotes synaptic transmission by targeting the NAD‐synthesizing enzyme dNmnat</article-title><source>EMBO Reports</source><volume>20</volume><elocation-id>e6975</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201846975</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneggenburger</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>AC</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse</article-title><source>Neuron</source><volume>23</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80789-8</pub-id><pub-id pub-id-type="pmid">10399944</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>KM</given-names></name><name><surname>Cox</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>8970</fpage><lpage>8980</lpage><pub-id pub-id-type="doi">10.1074/jbc.M512755200</pub-id><pub-id pub-id-type="pmid">16434393</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speese</surname><given-names>SD</given-names></name><name><surname>Trotta</surname><given-names>N</given-names></name><name><surname>Rodesch</surname><given-names>CK</given-names></name><name><surname>Aravamudan</surname><given-names>B</given-names></name><name><surname>Broadie</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy</article-title><source>Current Biology</source><volume>13</volume><fpage>899</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(03)00338-5</pub-id><pub-id pub-id-type="pmid">12781128</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>B</given-names></name><name><surname>Samaddar</surname><given-names>S</given-names></name><name><surname>Mylavarapu</surname><given-names>SVS</given-names></name><name><surname>Clement</surname><given-names>JP</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Homeostatic Scaling Is Driven by a Translation-Dependent Degradation Axis That Recruits MiRISC Remodeling</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.04.01.020164</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name><name><surname>Leslie</surname><given-names>KR</given-names></name><name><surname>Desai</surname><given-names>NS</given-names></name><name><surname>Rutherford</surname><given-names>LC</given-names></name><name><surname>Nelson</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Activity-dependent scaling of quantal amplitude in neocortical neurons</article-title><source>Nature</source><volume>391</volume><fpage>892</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1038/36103</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The self-tuning neuron: synaptic scaling of excitatory synapses</article-title><source>Cell</source><volume>135</volume><fpage>422</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.10.008</pub-id><pub-id pub-id-type="pmid">18984155</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Roessel</surname><given-names>P</given-names></name><name><surname>Elliott</surname><given-names>DA</given-names></name><name><surname>Robinson</surname><given-names>IM</given-names></name><name><surname>Prokop</surname><given-names>A</given-names></name><name><surname>Brand</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Independent regulation of synaptic size and activity by the anaphase-promoting complex</article-title><source>Cell</source><volume>119</volume><fpage>707</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.11.028</pub-id><pub-id pub-id-type="pmid">15550251</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Mering</surname><given-names>C</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>Snel</surname><given-names>B</given-names></name><name><surname>Hooper</surname><given-names>SD</given-names></name><name><surname>Krupp</surname><given-names>M</given-names></name><name><surname>Foglierini</surname><given-names>M</given-names></name><name><surname>Jouffre</surname><given-names>N</given-names></name><name><surname>Huynen</surname><given-names>MA</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>STRING: known and predicted protein-protein associations, integrated and transferred across organisms</article-title><source>Nucleic Acids Research</source><volume>33</volume><fpage>D433</fpage><lpage>D437</lpage><pub-id pub-id-type="doi">10.1093/nar/gki005</pub-id><pub-id pub-id-type="pmid">15608232</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>HI</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Fetter</surname><given-names>RD</given-names></name><name><surname>Bergstrom</surname><given-names>K</given-names></name><name><surname>Strauss</surname><given-names>R</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Highwire regulates synaptic growth in <italic>Drosophila</italic></article-title><source>Neuron</source><volume>26</volume><fpage>313</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)81166-6</pub-id><pub-id pub-id-type="pmid">10839352</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Engisch</surname><given-names>KL</given-names></name><name><surname>Rich</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Activity-dependent regulation of the binomial parameters p and n at the mouse neuromuscular junction in vivo</article-title><source>Journal of Neurophysiology</source><volume>104</volume><fpage>2352</fpage><lpage>2358</lpage><pub-id pub-id-type="doi">10.1152/jn.00460.2010</pub-id><pub-id pub-id-type="pmid">20739593</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wentzel</surname><given-names>C</given-names></name><name><surname>Delvendahl</surname><given-names>I</given-names></name><name><surname>Sydlik</surname><given-names>S</given-names></name><name><surname>Georgiev</surname><given-names>O</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dysbindin links presynaptic proteasome function to homeostatic recruitment of low release probability vesicles</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>267</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02494-0</pub-id><pub-id pub-id-type="pmid">29348419</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyhersmüller</surname><given-names>A</given-names></name><name><surname>Hallermann</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>N</given-names></name><name><surname>Eilers</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid active zone remodeling during synaptic plasticity</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>6041</fpage><lpage>6052</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6698-10.2011</pub-id><pub-id pub-id-type="pmid">21508229</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wondolowski</surname><given-names>J</given-names></name><name><surname>Dickman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Emerging links between homeostatic synaptic plasticity and neurological disease</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><elocation-id>223</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2013.00223</pub-id><pub-id pub-id-type="pmid">24312013</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>I</given-names></name><name><surname>Takagi</surname><given-names>H</given-names></name><name><surname>Ageta</surname><given-names>H</given-names></name><name><surname>Kahyo</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Hatanaka</surname><given-names>K</given-names></name><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Morone</surname><given-names>N</given-names></name><name><surname>Yuasa</surname><given-names>S</given-names></name><name><surname>Inokuchi</surname><given-names>K</given-names></name><name><surname>Ohtsuka</surname><given-names>T</given-names></name><name><surname>Macgregor</surname><given-names>GR</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Setou</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release</article-title><source>Cell</source><volume>130</volume><fpage>943</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.06.052</pub-id><pub-id pub-id-type="pmid">17803915</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokota</surname><given-names>T</given-names></name><name><surname>Mishra</surname><given-names>M</given-names></name><name><surname>Akatsu</surname><given-names>H</given-names></name><name><surname>Tani</surname><given-names>Y</given-names></name><name><surname>Miyauchi</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Nagai</surname><given-names>Y</given-names></name><name><surname>Sawada</surname><given-names>T</given-names></name><name><surname>Heese</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Brain site-specific gene expression analysis in Alzheimer’s disease patients</article-title><source>European Journal of Clinical Investigation</source><volume>36</volume><fpage>820</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2362.2006.01722.x</pub-id><pub-id pub-id-type="pmid">17032350</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>N</given-names></name><name><surname>Shabek</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ubiquitin ligases: structure, function, and regulation</article-title><source>Annual Review of Biochemistry</source><volume>86</volume><fpage>129</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-060815-014922</pub-id><pub-id pub-id-type="pmid">28375744</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71437.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brose</surname><given-names>Nils</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a7f6w43</institution-id><institution>Max Planck Institute of Experimental Medicine</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.06.16.448554" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.06.16.448554"/></front-stub><body><p>The paper focuses on presynaptic homeostatic plasticity (PHP) at the glutamatergic larval <italic>Drosophila</italic> neuromuscular synapse. In this facet of synaptic plasticity, the presynapse increases neurotransmitter release to compensate for diminished postsynaptic sensitivity. To study functional pathways and identify new molecular components of PHP, the authors carried out an electrophysiology-based genetic screen of E3 ubiquitin ligases – key regulators of protein function and degradation pathway and this screen, which forms the backbone of the paper, generated an extensive dataset encompassing 180 genotypes. In follow-up studies, the authors find that the E3 ligase Thin suppresses glutamate release, likely by targeting and downregulating Dysbindin, a transmitter-release-promoting presynaptic protein and based on the experimental data, a model is put forward according to which PHP arises by relieving Dysbindin of Thin-dependent ubiquitination and degradation. This is a strong paper that adds a highly interesting feature to the understanding of the molecular mechanisms that control synaptic strength.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71437.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a7f6w43</institution-id><institution>Max Planck Institute of Experimental Medicine</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Kawabe</surname><given-names>Hiroshi</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046fm7598</institution-id><institution>Gunma University</institution></institution-wrap><country>Japan</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Gundelfinger</surname><given-names>Eckart D</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zwmgk08</institution-id><institution>Leibniz Institute for Neurobiology, Magdeburg, Germany</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.06.16.448554">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.06.16.448554v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The E3 ligase Thin controls homeostatic plasticity through neurotransmitter release repression&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Lu Chen as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Hiroshi Kawabe (Reviewer #1); Eckart D Gundelfinger (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. There is consensus that your paper is a very strong <italic>eLife</italic> candidate, provided that the reviewers' comments can be addressed. Four items require additional data or experiments (see below).</p><p>Recommendations for the Authors</p><p>A. Revisions Requiring Additional Experiments</p><p>A1. Because global loss of Thin impairs muscle development, the authors re-express Thin solely in the muscle to study synaptic morphology in the absence of presynaptic thin (Figure 5). They find that in this situation presynaptic AZ numbers are significantly increased. The authors attribute this phenotype to unphysiological Thin levels in the muscle rather than to a loss of presynaptic Thin, because postsynaptic Thin overexpression in wild-type animals also increases AZ numbers. This attribution is not fully justifiable without additional data. The precise interpretation of the morphological phenotypes found is important to define the processes that are controlled by Thin. To clarify the issue the authors should analyse NMJ morphology upon presynaptically driven Thin-RNAi as used in the corresponding functional measurements (Figure 4).</p><p>A2. Thin was included in the screen in the form of a homozygous mutant allele (∆A) that was previously described to severely affect muscle integrity. As the authors admit, the corresponding reduced miniature amplitudes may confound conclusions – in particular as the QC is increased compared to control. This might imply that the mutant displays some capacity for homeostatic upregulation, at least on a long-term scale. However, Figure 3 shows that such a capacity is not apparent in the absence GluRIIA and that loss of Thin does not further reduce mini amplitudes when GluRIIA is missing. This leaves the reader puzzled without further information, especially on GluRII(A) abundance. It is only with Figure 4 that a motoneuronal RNAi is introduced, importantly with no discernible postsynaptic deficits. It is used to show that an increased RRP underlies increased baseline transmission, whereas SV release probability remains unchanged. The reviewers recommend to introduce this issue earlier (preferentially before Figure 3, which might actually become a supplementary figure) and to further elaborate to address short-term PHP deficits by performing PhTx experiments. Also, the morphological features (mainly Brp, as in Figure 5, maybe in combination with a SV marker) should be explored to increase comparability of the experiments.</p><p>A3. Based on the data provided, (partial) co-localization of Dysbindin and Thin at NMJs can only be deduced based on overexpression of fluorescently tagged proteins in motoneurons (Figure 6). This is a substantial shortcoming – but it is probably not easily overcome. Hence, it is important to verify that the two proteins affect each other. In S2 cells, overexpression of Dysbindin in S2 cells leads to striking recruitment of endogenous Thin to the periphery, actually to the very same hot spots (Figure 6). Here, controls are required to rule out that there are any 'bleed-through' effects (here from the green into the magenta channel), and a quantitative image analysis should be carried out. This could, in the best case, make a co-immunoprecipitation dispensable. Beyond this, the authors should explore the possibility of using a similar approach at NMJs instead of in S2 cells, comparing overexpression of tagged versions of Dysbindin alone and Thin alone vs. Dysbindin and Thin co-expressed, e.g. with using Synapsin (or Brp) as localization reference.</p><p>A4. It appears very important to test whether Dysbindin expression increases in the absence of Thin, possibly to an extent that endogenous protein becomes directly detectable by an antibody.</p><p>B. Revisions Requiring Further Data Analysis, Text Redaction, or Consideration</p><p>B1. The mammalian TRIM family is composed of dozens of members. The authors should provide a comparative domain and amino acid sequence analysis to support the notion that Thin is the TRIM32 ortholog. Corresponding sequence analyses could also serve as a basis to discuss related proteins in the fly and possible functional redundancies.</p><p>B2. As mentioned in the manuscript and shown by others, presynaptic Dysbindin overexpression increases neurotransmitter release. This is consistent with the model put forward in the current manuscript. Related to increased AZ numbers observed (Figure 5), which the authors do not attribute to loss of presynaptic Thin, the questions arises as to whether presynaptic Dysbindin overexpression increases AZ numbers. If this were not the case, it would support the authors' model, where the Thin-Dysbindin interaction influences synaptic strength at the level of an individual synapse. If the authors already have data related to this issue, they should be included.</p><p>B3. The statement that distinct Thin and Dysbindin spots partially overlap is based on nice, high-resolution STED images. However, in terms of quantification the authors only show a single line profile. A more quantitative correlation analysis would strengthen the conclusion and improve the manuscript.</p><p>B4. The authors argue that presynaptic Thin remains hardly detectable because of the dominant expression in muscles. The question arises as to whether staining of NMJs in animals with muscle-specific Thin RNAi might overcome this issue and provide information on presynaptic Thin.</p><p>B5. The question arises whether there is an observable effect of PhTX treatment on the level of tagged Dysbindin that can be addressed by live imaging.</p><p>B6. The cumulative evidence indicates that under baseline conditions, Thin limits SV release via control of Dysbindin (Figure 7). Given that the screen identified quite a few E3 ligases, the question arises as to whether there are candidates in the screen that could be included as example where PHP is affected independently of Dysbindin.</p><p>B7. The authors' measure of release probability (Pr) is related to the estimated RRP size, which should be treated with care (see e.g. Neher, Merits and limitations of vesicle pool models in view of heterogeneous populations of synaptic vesicles, Neuron, 2015). For an additional and independent assessment of Pr, the authors should quantify the ratio of 1st and 2nd EPSCs in the 60 Hz trains.</p><p>C. Other Issues Requiring Attention</p><p>C1. The exact genotypes of all of the <italic>Drosophila</italic> lines used in this study need to be listed in a clear and comprehensive fashion to provide this important information to the reader – analogous to or in Table S1. Ideally, the red colour code of genes in Figure 1E could be used for this new information and for the 'old' Table S1.</p><p>C2. Flybase lists 5 publicly available Thin-specific RNAi lines (3 at Bloomington, 2 at VDRC), but the line that was used here seems not to have been specified. This should be rectified. The authors should explain why the specific line was used and whether the use of alternative RNAi lines was considered to validate the observed phenotype and rule out off-target effects.</p><p>C3. For the sake of consistency, the genotype thin<sup>ΔA</sup>; 24BGal4&gt;UAS-thin should either be consistently referred to as 'postsynaptic rescue' (Figure 2) or as 'presynaptic thin<sup>ΔA</sup> mutant' (Figure 5) throughout the manuscript.</p><p>C4. The reviewers noticed inconsistencies in the methods section concerning cloning experiments. The mCherry-tagged Thin construct is once referred to as &quot;pUAS_attB_mCherry_thin vector&quot; in the paragraph on plasmid construction, but as &quot;pUAS-thin-mCherry&quot; in the previous paragraph, and as &quot;UAS-thinmcherry&quot; in the Results section. The construct descriptor should be consistent throughout the manuscript. Brief inspection of the primer sequences indicates that mCherry was fused to the C-terminus of Thin, but the restriction sites within the primers do not all match the enzymes that are named as the ones used for cloning. Finally, the authors should indicate which of the Thin splice variants was expressed from the UAS transgene.</p><p>C5. The reviewers noted possible inconsistencies in Figure 2. In the top right set of example traces in Figure 2A, the large pink and red traces show a clear difference, which is reflected in the second set of bar diagrams in Figure 2C (i.e. pink and red bars). On the other hand, sky-blue and blue traces on the bottom left in Figure 2A show no difference while the third set of bar diagrams in Figure 2C (i.e. sky blue and blue bars) show a significant difference. This should be explained. In the experiments shown in Figure 4, the authors knocked down Thin in the presynaptic neuron with an intact expression in postsynaptic muscle cells. In Figure 4C, it is shown that this treatment increases EPSCs. This scenario is similar to that in the Thin KO with postsynaptic rescue, shown in Figure 2C (light green bar). However, no difference between gray and light green bars in Figure 2C is apparent. It is unclear how this can be explained.</p><p>C6. Figure 5 and Figure S2 indicate striking changes regarding the AZ protein Brp that occur alongside postsynaptic expression of Thin, regardless of WT or mutant background. This might imply an interesting 'retrograde' effects. It might be a good idea to provide a comment on this finding. Further, it seems that at least the Brp labellings in Figure 5 do not at all reflect the different intensities shown in the corresponding graphs. This needs to be explained or other images should be chosen.</p><p>C7. The reviewers interpret the images in Figure 6A-6D to originate from mcherry and venus. If so, they should be indicated as such i.e. &quot;Thin-mcherry&quot; and &quot;Dysb-venus&quot; in panels A-D. Otherwise, the reader might assume that endogenous untagged proteins are shown.</p><p>C8. There are shortcomings in the documentation of the biochemical part of the cell culture experiments. The Western Blot in Figure 6E is not labelled properly (band at 25 kDa in bottom panel), the bands shown do not really match the data in the bar graph in Figure 6F (e.g. the thin2x sample), and it is unclear what normalization and loading control were used (requires MEMCode or housekeeping protein quantification), and what type of tissue samples from exactly what genotypes were loaded. This should be rectified. Further, there is a faint band at &gt;50 kDa in all lanes of the upper panel of Figure 6E, even in the thin2x lane. This should be discussed. The legend should note that Dysb-Venus was detected with anti-GFP antibodies. The expression level of Thin appears to have been assessed only by the concentration of the transfected DNA rather than by blot analysis or at least determining the actual rate of transfected cells. If true, this should be stated. Further, the methods section mentions that Thin-mCherry was used for transfection and anti-DsRed antibody for detection on blots, but no corresponding results are described.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;The E3 ligase Thin controls homeostatic plasticity through neurotransmitter release repression&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Lu Chen (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved very substantially. No further experiments are required, but there are five remaining issues that need to be addressed by changes to the manuscript, as outlined below:</p><p>1. The authors state in their rebuttal that &quot;Under baseline conditions, i.e. in the absence of PhTX, the miniature amplitude was decreased in thinΔA mutants (Figure 2B), after presynaptic and postsynaptic rescue (Figure 2B)&quot;. However, in Figure 2B, the gray and light red bars show significant differences, while gray and light blue/light green bars do not. This indicates that mEPSC amplitudes were NOT decreased in thinΔA mutants upon presynaptic or postsynaptic rescue. Can this be clarified or is there an underlying asterisk labeling error? The latter, if relevant, might warrant a final detailed check of the entire manuscript.</p><p>2. Demonstrating an increase in Dysbindin levels in thin mutants is important. Many reports have demonstrated reduced expression of alleged &quot;substrates&quot; upon overexpression of a corresponding E3 – as shown in Figure 5. Figure S2C. However, such results have limited value. Overexpression of an E3 can cause artificial ubiquitination by excess enzyme binding with low-affinity to proteins that are not endogenous substrates. Since it is not difficult to detect Dysbindin-Venus by Western blotting, the best experiment under the current circumstances might be to study thin mutant flys expressing low levels of Dysbindin-Venus. At this juncture, the reviewers do not require this experiment to be done. Instead, the authors should conservatively rephrase their conclusion that Dysbindin is regulated by the UPS in a Thin-dependent manner (Figure 6F) and might eliminate &quot;26S&quot; from Figure 6F and change the text accordingly.</p><p>3. There appears to be a misunderstanding regarding the reviewers' comment C5 – the concerns regarding discrepancies between Figure 2C and Figure 4C. In the reviewers' view, the expression of thin should be the same in these two scenarios; no thin expression in presynapse but intact expression in postsynapse. There should not be any difference between the results in Figure 2C and Figure 4C. This issue should be explained and resolved.</p><p>4. The identity of the transgenic lines shown in Figure 1E should be disclosed. The authors have done a good job of listing all genotypes. However, in its present form, the assignment of individual genotypes to data points on the volcano plot cannot be clearly extracted from the supplementary table. As a compromise, the authors could use the red colour code in the table as previously suggested (comment C1).</p><p>5. To avoid word repetition, the reviewers suggest slightly rephrasing the sentence &quot;Regarding the decrease in Brp intensity, Brp intensity was decreased…&quot; (lines 230-231).</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71437.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. There is consensus that your paper is a very strong eLife candidate, provided that the reviewers' comments can be addressed. Four items require additional data or experiments (see below).</p><p>Recommendations for the Authors</p><p>A. Revisions Requiring Additional Experiments</p><p>A1. Because global loss of Thin impairs muscle development, the authors re-express Thin solely in the muscle to study synaptic morphology in the absence of presynaptic thin (Figure 5). They find that in this situation presynaptic AZ numbers are significantly increased. The authors attribute this phenotype to unphysiological Thin levels in the muscle rather than to a loss of presynaptic Thin, because postsynaptic Thin overexpression in wild-type animals also increases AZ numbers. This attribution is not fully justifiable without additional data. The precise interpretation of the morphological phenotypes found is important to define the processes that are controlled by Thin. To clarify the issue the authors should analyse NMJ morphology upon presynaptically driven Thin-RNAi as used in the corresponding functional measurements (Figure 4).</p></disp-quote><p>We fully agree. As suggested, we investigated presynaptic NMJ morphology after presynaptic thin-RNAi expression. In addition, we examined NMJ morphology in homozygous thin<sup>ΔA</sup> mutants. While we observed a slight increase in Brp number after presynaptic thin-RNAi expression (new Figure 4—figure supplement 1), Brp number and NMJ area were unchanged in thin<sup>ΔA</sup> mutants (new Figure 3). The observation of largely unchanged NMJ area and Brp number in thin null mutants (new Figure 3), which display a complete PHP block and increased presynaptic release (Figure 2), provides strong genetic evidence that the defects in synaptic physiology are unlikely a consequence of increased NMJ size or AZ number. Conversely, PHP and baseline synaptic transmission were unaffected at NMJs with increased NMJ area and Brp number after postsynaptic thin expression in wild type (new Figure 3—figure supplement 1). Thus, although we cannot exclude that the changes in NMJ size or AZ number seen after postsynaptic thin rescue or presynaptic thin-RNAi expression contribute to the changes in synaptic physiology, our data suggest that the changes in NMJ area and AZ number are separable from changes in synaptic physiology. We updated the Results and Discussion sections correspondingly. =&gt; See Results (l. 209), and Discussion (l. 389).</p><disp-quote content-type="editor-comment"><p>A2. Thin was included in the screen in the form of a homozygous mutant allele (∆A) that was previously described to severely affect muscle integrity. As the authors admit, the corresponding reduced miniature amplitudes may confound conclusions – in particular as the QC is increased compared to control. This might imply that the mutant displays some capacity for homeostatic upregulation, at least on a long-term scale. However, Figure 3 shows that such a capacity is not apparent in the absence GluRIIA and that loss of Thin does not further reduce mini amplitudes when GluRIIA is missing. This leaves the reader puzzled without further information, especially on GluRII(A) abundance. It is only with Figure 4 that a motoneuronal RNAi is introduced, importantly with no discernible postsynaptic deficits. It is used to show that an increased RRP underlies increased baseline transmission, whereas SV release probability remains unchanged. The reviewers recommend to introduce this issue earlier (preferentially before Figure 3, which might actually become a supplementary figure) and to further elaborate to address short-term PHP deficits by performing PhTx experiments. Also, the morphological features (mainly Brp, as in Figure 5, maybe in combination with a SV marker) should be explored to increase comparability of the experiments.</p></disp-quote><p>As recommended, we investigated PHP after presynaptic thin-RNAi expression and observed a complete PHP block (Figure 4—figure supplement 1), consistent with the thin<sup>ΔA</sup> mutant data (Figure 2). Furthermore, we probed Brp and NMJ morphology after presynaptic thin-RNAi expression (see A1, Figure 4—figure supplement 1).</p><p>Regarding the reduced miniature amplitude in thin<sup>ΔA</sup> mutants: Under baseline conditions, i.e. in the absence of PhTX, miniature amplitude was decreased in thin<sup>ΔA</sup> mutants (Figure 2B), after presynaptic and postsynaptic rescue (Figure 2B), and largely unchanged upon presynaptic thin-RNAi expression (Figure 4B). Quantal content was increased in thin<sup>ΔA</sup> mutants (Figure 2E), after postsynaptic rescue (Figure 2E), and after presynaptic thin-RNAi expression (Figure 4D). Together, these data imply that the increase in quantal content under baseline conditions induced by presynaptic thin manipulations is separable from a decrease in miniature amplitude.</p><p>By definition, PHP is induced by a relative decrease in miniature amplitude. Given that quantal content increased after presynaptic thin manipulations independent of changes in miniature amplitude (see last paragraph), we consider it unlikely that the increased quantal content under baseline conditions represents a homeostatic response.</p><p>Miniature amplitude was decreased in thin<sup>ΔA</sup>-GluRIIA double mutants compared to thin<sup>ΔA</sup> mutants (Figure 2—figure supplement 1B). While a decrease in miniature amplitude induced an increase in quantal content in GluRIIA mutants compared to WT (Figure 2—figure supplement 1D), there was no increase in quantal content in thin<sup>ΔA</sup>-GluRIIA double mutants compared to thin<sup>ΔA</sup> mutants (Figure 2— figure supplement 1D), implying a PHP defect.</p><p>Indeed, miniature amplitude was similar between GluRIIA mutants and thin<sup>ΔA</sup>GluRIIA double mutants (Figure 2—figure supplement 1B). This observation either indicates that we could not resolve a further decrease in miniature amplitude because of signal-to-noise limitations, or that loss of thin reduces GluR levels. Importantly, while miniature amplitudes were similar between GluRIIA mutants and thin<sup>ΔA</sup>-GluRIIA double mutants (Figure 2—figure supplement 1B), EPSC amplitudes were decreased in thin<sup>ΔA</sup>-GluRIIA double mutants, but not in GluRIIA mutants (Figure 2—figure supplement 1C). This suggests a thin-dependent decrease in EPSC amplitude in the GluRIIA mutant background, consistent with impaired PHP.</p><p>We summarized and discussed these points in the Discussion (l. 428) and the legend of Figure 2—figure supplement 1.</p><p>As suggested, we now show the GluRIIA data as a supplementary figure (Figure 2—figure supplement 1). Based on the fact that we now quantified NMJ morphology in thin<sup>ΔA</sup> mutants (Figure 3, A1), and that we carried out the formal genetic analysis with presynaptic and postsynaptic rescue in the thin<sup>ΔA</sup> mutant background (Figure 2), we decided showing the morphology data for thin<sup>ΔA</sup> mutants and rescue experiments (new Figure 3) before introducing the thin-RNAi physiology and morphology data (Figure 4 and Figure 4—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>A3. Based on the data provided, (partial) co-localization of Dysbindin and Thin at NMJs can only be deduced based on overexpression of fluorescently tagged proteins in motoneurons (Figure 6). This is a substantial shortcoming – but it is probably not easily overcome. Hence, it is important to verify that the two proteins affect each other. In S2 cells, overexpression of Dysbindin in S2 cells leads to striking recruitment of endogenous Thin to the periphery, actually to the very same hot spots (Figure 6). Here, controls are required to rule out that there are any 'bleed-through' effects (here from the green into the magenta channel), and a quantitative image analysis should be carried out. This could, in the best case, make a co-immunoprecipitation dispensable. Beyond this, the authors should explore the possibility of using a similar approach at NMJs instead of in S2 cells, comparing overexpression of tagged versions of Dysbindin alone and Thin alone vs. Dysbindin and Thin co-expressed, e.g. with using Synapsin (or Brp) as localization reference.</p></disp-quote><p>We performed additional experiments and analyses regarding the relationship between Thin and Dysbindin localization in S2 cells and at the NMJ. As recommended, we first investigated a potential bleed-through between the Dysbindin and Thin channel in S2 cells: To test whether the Thin channel (magenta) is excited by the Dysbindin channel (green), we only expressed dysbindin in S2 cells and imaged both channels. Fluorescence intensity did not significantly deviate from background in the Thin channel (magenta) (Figure 5—figure supplement 2A), suggesting no major bleed through from the Dysbindin to the Thin channel. It is also worth noting that both channels were imaged sequentially when expressing both, dysbindin and thin (Figure 5—figure supplement 2A). Finally, although tightly correlated, we also observed a small fraction of uncorrelated Dysbindin and Thin fluorescence (Figure 5—figure supplement 2A). Hence, we consider a major contribution of channel crosstalk to the Dysbindin and Thin localization data in S2 cells unlikely.</p><p>Next, we quantified the Pearson’s correlation coefficient (r) for Thin and</p><p>Dysbindin fluorescence intensity per pixel in S2 cells and found an average r=0.84</p><p>(Figure 5—figure supplement 2B), significantly higher than expected from random Thin and Dysbindin localizations simulated by sampling random point spread function-sized chunks of the data (Figure 5—figure supplement 2B and Material and Methods).</p><p>Finally, we studied the relationship between Thin and Dysbindin localization at the NMJ by quantifying the nearest-neighbor distances (NNDs) between Thin and Dysbindin puncta at STED resolution upon overexpression (Figure 5). This analysis revealed significantly smaller NNDs between Thin and Dysbindin puncta compared to simulated random localizations within NMJ boutons (Figure 5). Collectively, these data suggest a relationship between Thin and Dysbindin localization in S2 cells and at the NMJ.</p><p>Additionally, we probed Dysbindin localization after overexpression with regard to Synapsin localization at the NMJ of wild type and thin<sup>ΔA</sup> mutants using STED microscopy. Although we revealed a slight, but significant decrease in NND between Dysbindin and Synapsin puncta in thin<sup>ΔA</sup> mutants compared to wild type, we also detected a slight increase in Synapsin puncta density in thin<sup>ΔA</sup> mutants, thereby complicating the interpretation of the results of this experiment. We therefore decided against including these data into the manuscript.</p><disp-quote content-type="editor-comment"><p>A4. It appears very important to test whether Dysbindin expression increases in the absence of Thin, possibly to an extent that endogenous protein becomes directly detectable by an antibody.</p></disp-quote><p>We now performed an anti-dysbindin staining in the thin<sup>ΔA</sup> mutant background. Unfortunately, we failed to detect a significant anti-dysbindin signal over background fluorescence in thin<sup>ΔA</sup> mutants. It is worth noting that we quite commonly fail in detecting proteins with low endogenous levels by immunohistochemistry at the <italic>Drosophila</italic> NMJ.</p><disp-quote content-type="editor-comment"><p>B. Revisions Requiring Further Data Analysis, Text Redaction, or Consideration</p><p>B1. The mammalian TRIM family is composed of dozens of members. The authors should provide a comparative domain and amino acid sequence analysis to support the notion that Thin is the TRIM32 ortholog. Corresponding sequence analyses could also serve as a basis to discuss related proteins in the fly and possible functional redundancies.</p></disp-quote><p>We carried out a comparative domain and amino acid sequence analysis between Thin and the human TRIM family (Figure 1—figure supplement 2). Consistent with previous work (LaBeau-DiMenna et al., 2012), this analysis suggests that TRIM32 likely represents the closest human ortholog of thin. In short, out of the large TRIM family, TRIM32 is the only TRIM that has a domain composition that is similar to the one of Thin (N-terminal TRIM followed by C-terminal NHL repeats; Figure 1—figure supplement 2A). Moreover, amino acid sequence alignment of Thin’s RING domains and NHL domains revealed evolutionary conservation of both domains compared to TRIM32, as well as other members of the TRIM C-VII family, which also contains TRIM32 (Ozato et al., 2008; Figure 1—figure supplement 2B). Together, this analysis supports the idea that TRIM32 is Thin’s closest human ortholog.</p><p>We updated the manuscript accordingly (l. 142, Figure 1—figure supplement 2).</p><disp-quote content-type="editor-comment"><p>B2. As mentioned in the manuscript and shown by others, presynaptic Dysbindin overexpression increases neurotransmitter release. This is consistent with the model put forward in the current manuscript. Related to increased AZ numbers observed (Figure 5), which the authors do not attribute to loss of presynaptic Thin, the questions arises as to whether presynaptic Dysbindin overexpression increases AZ numbers. If this were not the case, it would support the authors' model, where the Thin-Dysbindin interaction influences synaptic strength at the level of an individual synapse. If the authors already have data related to this issue, they should be included.</p></disp-quote><p>Based on your suggestion, we probed Brp number and NMJ morphology after dysbindin overexpression. This analysis did not yield differences in Brp number or NMJ area compared to controls (Figure 5—figure supplement 1F), thereby further supporting the notion that changes in AZ number/NMJ size are separable from changes in synaptic physiology (see also A1).</p><disp-quote content-type="editor-comment"><p>B3. The statement that distinct Thin and Dysbindin spots partially overlap is based on nice, high-resolution STED images. However, in terms of quantification the authors only show a single line profile. A more quantitative correlation analysis would strengthen the conclusion and improve the manuscript.</p></disp-quote><p>We now quantified the nearest-neighbor distances (NNDs) between Thin and Dysbindin puncta at STED resolution upon overexpression (Figure 5) and observed significantly smaller NNDs between Thin and Dysbindin puncta compared to randomly distributed puncta (Figure 5, see also A3). Note that we decided against conducting a fluorescence intensity-based correlation analysis, because the comparably low fluorescence intensity of STED data has a rather small dynamic range, thus complicating a correlation analysis.</p><disp-quote content-type="editor-comment"><p>B4. The authors argue that presynaptic Thin remains hardly detectable because of the dominant expression in muscles. The question arises as to whether staining of NMJs in animals with muscle-specific Thin RNAi might overcome this issue and provide information on presynaptic Thin.</p></disp-quote><p>Based on this suggestion, we probed endogenous Thin localization in relation to Brp in WT and thin<sup>ΔA</sup> mutants and observed anti-thin fluorescence in close proximity to Brp in WT, but not in thin<sup>ΔA</sup> mutants (Figure 5—figure supplement 1D, E). These data suggest that endogenous Thin localizes to presynaptic boutons in addition to postsynaptic muscle cells. We did not repeat these experiments after muscle-specific RNAi expression due to time reasons (l. 292).</p><disp-quote content-type="editor-comment"><p>B5. The question arises whether there is an observable effect of PhTX treatment on the level of tagged Dysbindin that can be addressed by live imaging.</p></disp-quote><p>We conducted this experiment but did not detect obvious differences in anti-GFP fluorescence intensity or localization after venus-dysbindin overexpression between PhTX-treated and untreated NMJs (not shown).</p><disp-quote content-type="editor-comment"><p>B6. The cumulative evidence indicates that under baseline conditions, Thin limits SV release via control of Dysbindin (Figure 7). Given that the screen identified quite a few E3 ligases, the question arises as to whether there are candidates in the screen that could be included as example where PHP is affected independently of Dysbindin.</p></disp-quote><p>Incorporation of other candidate genes identified by the genetic screen would presuppose a rather elaborate set of experiments (genetic rescue, morphology, relationship to dysbindin etc.), similar to the one presented for <italic>thin</italic> in the present study. The realization of these experiments was not feasible during the revision.</p><disp-quote content-type="editor-comment"><p>B7. The authors' measure of release probability (Pr) is related to the estimated RRP size, which should be treated with care (see e.g. Neher, Merits and limitations of vesicle pool models in view of heterogeneous populations of synaptic vesicles, Neuron, 2015). For an additional and independent assessment of Pr, the authors should quantify the ratio of 1st and 2nd EPSCs in the 60 Hz trains.</p></disp-quote><p>We now analyzed the paired-pulse ratio (PPR) of the first two EPSC amplitudes of the 60-Hz train. There was a slight increase in PPR after presynaptic thin-RNAi expression compared to controls (Figure 4H), implying a slight decrease in release probability (pr). By contrast, the train-based pr estimate (first EPSC amplitude/ cum. EPSC amplitude) was similar between thin-RNAi and controls (Figure 4G). Together, these data suggest that the increase in presynaptic release upon presynaptic thinRNAi expression is unlikely caused by an increase in pr, and that presynaptic thinRNAi expression may even lead to a slight pr decrease. We updated the Results section accordingly (l. 263).</p><disp-quote content-type="editor-comment"><p>C. Other Issues Requiring Attention</p><p>C1. The exact genotypes of all of the <italic>Drosophila</italic> lines used in this study need to be listed in a clear and comprehensive fashion to provide this important information to the reader – analogous to or in Table S1. Ideally, the red colour code of genes in Figure 1E could be used for this new information and for the 'old' Table S1.</p></disp-quote><p>We updated the manuscript and Table S1 with regard to the exact genotypes (Table S1).</p><disp-quote content-type="editor-comment"><p>C2. Flybase lists 5 publicly available Thin-specific RNAi lines (3 at Bloomington, 2 at VDRC), but the line that was used here seems not to have been specified. This should be rectified. The authors should explain why the specific line was used and whether the use of alternative RNAi lines was considered to validate the observed phenotype and rule out off-target effects.</p></disp-quote><p>We used Bloomington stock 42826 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_42826">BDSC_42826</ext-link>; P{TRiP.HMS02508}attP40). Out of the four stocks available from Bloomington, three express dsRNA for RNAi of thin under UAS control in the pVALIUM20 vector, one of the second-generation TRiP knockdown vectors (Ni et al., 2011; Perkins et al., 2015). The other line available from Bloomington was made with the older, firstgeneration pVALIUM1 vector. Out of the three VALIUM20 stocks available, we used stock 42826, because it is the only one that was previously published in the context of genetic screens (Kuleesha et al., 2016, Rotelli et al., 2019). We neither ordered nor tested additional thin RNAi lines from Bloomington or VDRC because of time reasons. We updated the methods section correspondingly (Key resources table, an l. 482).</p><disp-quote content-type="editor-comment"><p>C3. For the sake of consistency, the genotype thin <sup>ΔA</sup>; 24BGal4&gt;UAS-thin should either be consistently referred to as 'postsynaptic rescue' (Figure 2) or as 'presynaptic thin <sup>ΔA</sup> mutant' (Figure 5) throughout the manuscript.</p></disp-quote><p>We now consistently use the term ‘postsynaptic rescue’ throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>C4. The reviewers noticed inconsistencies in the methods section concerning cloning experiments. The mCherry-tagged Thin construct is once referred to as &quot;pUAS_attB_mCherry_thin vector&quot; in the paragraph on plasmid construction, but as &quot;pUAS-thin-mCherry&quot; in the previous paragraph, and as &quot;UAS-thinmcherry&quot; in the Results section. The construct descriptor should be consistent throughout the manuscript. Brief inspection of the primer sequences indicates that mCherry was fused to the C-terminus of Thin, but the restriction sites within the primers do not all match the enzymes that are named as the ones used for cloning. Finally, the authors should indicate which of the Thin splice variants was expressed from the UAS transgene.</p></disp-quote><p>We are sorry about these inconsistencies and now consistently labelled the construct as “pUAS-mCherry-thin”, “Thin<sup>mCherry</sup>”. Moreover, we added the correct primer sequences and the Ref.Seq number for the expressed Thin isoform (isoform A) to the methods section (Material and Methods, l. 509).</p><p>Note that we now performed additional cloning experiments for the new Western blot analysis (see C8).</p><disp-quote content-type="editor-comment"><p>C5. The reviewers noted possible inconsistencies in Figure 2. In the top right set of example traces in Figure 2A, the large pink and red traces show a clear difference, which is reflected in the second set of bar diagrams in Figure 2C (i.e. pink and red bars). On the other hand, sky-blue and blue traces on the bottom left in Figure 2A show no difference while the third set of bar diagrams in Figure 2C (i.e. sky blue and blue bars) show a significant difference. This should be explained. In the experiments shown in Figure 4, the authors knocked down Thin in the presynaptic neuron with an intact expression in postsynaptic muscle cells. In Figure 4C, it is shown that this treatment increases EPSCs. This scenario is similar to that in the Thin KO with postsynaptic rescue, shown in Figure 2C (light green bar). However, no difference between gray and light green bars in Figure 2C is apparent. It is unclear how this can be explained.</p></disp-quote><p>Regarding the representative presynaptic thin rescue data (sky blue and dark blue, Figure 2): We apologize for having chosen a representative cell for the presynaptic rescue group with PhTX (dark blue) that did not reflect the group average and now updated the example trace correspondingly (dark blue traces in Figure 2A). Most likely, the difference in EPSC amplitude between PhTX-treated and untreated cells after presynaptic thin rescue is a result of incomplete rescue, a phenomenon quite frequently observed after overexpression-based genetic rescue at the <italic>Drosophila</italic> NMJ. Alternatively, the smaller EPSC amplitudes after rescue may arise from defects in muscle architecture (LaBeau-DiMenna et al., 2012). Note, however, that there was a significant increase in quantal content after presynaptic rescue (Figure 2D), suggesting a partial PHP rescue. We now discuss this in the updated Results section (l. 160).</p><p>Concerning the comparison of EPSC amplitudes between thin<sup>ΔA</sup> presynaptic rescue (Figure 2C) and presynaptic thin-RNAi (Figure 4C): If we understand the concern correctly, then the question is why the increase in EPSC amplitude after presynaptic thin-RNAi expression (Figure 4C) is more pronounced than the one after postsynaptic rescue (Figure 2C, light green data). The short answer is that this is most likely due to different effects on mEPSC amplitude in these genetic backgrounds: mEPSC amplitudes were decreased in thin<sup>ΔA</sup> (Figure 2B, light red) and – to a lesser extend – after postsynaptic rescue (Figure 2B, light green), but largely unchanged after presynaptic thin-RNAi expression (Figure 4B). In combination with largely unchanged EPSC amplitudes in thin<sup>ΔA</sup> (Figure 2C, light red), slightly increased EPSC amplitudes after postsynaptic rescue (Figure 2C, light green), and increased EPSP amplitudes after presynaptic thin-RNAi expression (Figure 4C), this translates into a similar increase in quantal content in these three genotypes (Figure 2E and 4D). Hence, thin perturbation results in enhanced neurotransmitter release under baseline conditions in three independent experiments.</p><p>We discuss the relationship between miniature amplitude and presynaptic release in the Discussion (l. 428).</p><disp-quote content-type="editor-comment"><p>C6. Figure 5 and Figure S2 indicate striking changes regarding the AZ protein Brp that occur alongside postsynaptic expression of Thin, regardless of WT or mutant background. This might imply an interesting 'retrograde' effects. It might be a good idea to provide a comment on this finding. Further, it seems that at least the Brp labellings in Figure 5 do not at all reflect the different intensities shown in the corresponding graphs. This needs to be explained or other images should be chosen.</p></disp-quote><p>Indeed, Brp intensity was decreased in thin<sup>ΔA</sup> mutants, after presynaptic rescue (Figure 3E), and postsynaptic thin overexpression in wild type (new Figure 3—figure supplement 1E). We also observed a trend towards decreased Brp intensity after postsynaptic rescue (Figure 3). However, while Brp intensity was decreased after presynaptic rescue (new Figure 3) and postsynaptic thin overexpression (new Figure 3—figure supplement 1), PHP and baseline synaptic transmission were unchanged in both genotypes (Figure 2, new Figure 3—figure supplement 1). Conversely, Brp levels were unaffected by presynaptic thin-RNAi expression, but PHP was impaired, and baseline synaptic transmission increased (Figure 4, new Figure 4—figure supplement 1). Together, these results again support the idea that changes in NMJ morphology are separable from changes in synaptic physiology after genetic thin manipulations (see A1). Although possible, we therefore consider it unlikely that the decrease in Brp intensity is a major factor underlying the PHP defect or the increase in synaptic transmission after presynaptic thin perturbation.</p><p>We now discuss the changes in Brp intensity in the Results (l. 209) and Discussion sections (l. 389).</p><p>Finally, we updated the example image in the new version of Figure 3 to better reflect the average Brp data.</p><disp-quote content-type="editor-comment"><p>C7. The reviewers interpret the images in Figure 6A-6D to originate from mcherry and venus. If so, they should be indicated as such i.e. &quot;Thin-mcherry&quot; and &quot;Dysb-venus&quot; in panels A-D. Otherwise, the reader might assume that endogenous untagged proteins are shown.</p></disp-quote><p>We apologize for not specifying the tag in the images. As specified in the figure legend, the images indeed show pUAS-mCherry-thin (‘Thin<sup>mCherry</sup>’) and pUAS-venusDysbindin (‘Dysbindin<sup>venus</sup>’). We updated the new Figure 5 correspondingly.</p><disp-quote content-type="editor-comment"><p>C8. There are shortcomings in the documentation of the biochemical part of the cell culture experiments. The Western Blot in Figure 6E is not labelled properly (band at 25 kDa in bottom panel), the bands shown do not really match the data in the bar graph in Figure 6F (e.g. the thin2x sample), and it is unclear what normalization and loading control were used (requires MEMCode or housekeeping protein quantification), and what type of tissue samples from exactly what genotypes were loaded. This should be rectified. Further, there is a faint band at &gt;50 kDa in all lanes of the upper panel of Figure 6E, even in the thin2x lane. This should be discussed. The legend should note that Dysb-Venus was detected with anti-GFP antibodies. The expression level of Thin appears to have been assessed only by the concentration of the transfected DNA rather than by blot analysis or at least determining the actual rate of transfected cells. If true, this should be stated. Further, the methods section mentions that Thin-mCherry was used for transfection and anti-DsRed antibody for detection on blots, but no corresponding results are described.</p></disp-quote><p>We are sorry about the shortcomings regarding the documentation of the biochemistry and cell culture experiments. Based on this concern, we repeated the Western blot analysis. Since it was difficult to detect mCherry-tagged Thin, we generated and expressed HA-tagged Thin (pUAS-HA-thin). However, it was also challenging to detect pUAS-HA-thin on Western blots (Figure 5—figure supplement 2C). This may be due to Thin’s large disordered domains and/or its comparably large size (Figure 1—figure supplement 2A). Quantification of the Thin/Tubulin ratio at 1x and 2x thin DNA concentration revealed an increase of Thin/Tubulin that correlated with HA-thin DNA concentration (not shown). However, the low signal-to-noise ratio of the Thin signal precludes a meaningful quantification and interpretation of these data. We thus plotted Dysbindin/Tubulin for cells transfected without, 1x and 2x pUAS-HA-thin (now specified in the Methods section). Note that we are confident about a robust thin transfection efficiency, because we consistently observed mCherry-positive cells in the old experiments, as well as anti-HA signal in the last rounds of Western blots.</p><p>We chose a new example that better reflects the average data (Figure 5— figure supplement 2C). Note that – besides the fact that most blots showed some ‘cosmetic flaws’ (Figure 5—figure supplement 2C); we explicitly show a representative instead of the best example – we consistently observed a reduction in anti-GFP/anti-Tubulin that correlated with pUAS-HA-thin concentration, thereby strongly supporting the idea that Thin degrades Dysbindin in <italic>Drosophila</italic>.</p><p>The new blot does not display faint bands at &gt;60kDa. We also verified that the new blot is labelled correctly, including the correct molecular sizes.</p><p>The legend now specifies that pUAS-venus-Dysbindin (‘Dysbindin<sup>venus</sup>’) and pUAS-HA-thin (‘Thin<sup>HA</sup>’) were detected with anti-GFP and anti-HA, respectively. The quantification of anti-GFP (Dysbindin<sup>venus</sup>) was now normalized to anti-Tubulin (Figure 5—figure supplement 2D). The Methods section was updated correspondingly.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved very substantially. No further experiments are required, but there are five remaining issues that need to be addressed by changes to the manuscript, as outlined below:</p><p>1. The authors state in their rebuttal that &quot;Under baseline conditions, i.e. in the absence of PhTX, the miniature amplitude was decreased in thinΔA mutants (Figure 2B), after presynaptic and postsynaptic rescue (Figure 2B)&quot;. However, in Figure 2B, the gray and light red bars show significant differences, while gray and light blue/light green bars do not. This indicates that mEPSC amplitudes were NOT decreased in thinΔA mutants upon presynaptic or postsynaptic rescue. Can this be clarified or is there an underlying asterisk labeling error? The latter, if relevant, might warrant a final detailed check of the entire manuscript.</p></disp-quote><p>mEPSC amplitudes were decreased after presynaptic rescue (p&lt;0.001) and</p><p>postsynaptic rescue (p=0.04) in the thinΔA mutant background compared to WT. Hence, there was indeed an asterisk labeling error in Figure 2B. We are sorry about this mistake and thank the reviewers for catching it. We now updated Figure 2B correspondingly.</p><disp-quote content-type="editor-comment"><p>2. Demonstrating an increase in Dysbindin levels in thin mutants is important. Many reports have demonstrated reduced expression of alleged &quot;substrates&quot; upon overexpression of a corresponding E3 – as shown in Figure 5. Figure S2C. However, such results have limited value. Overexpression of an E3 can cause artificial ubiquitination by excess enzyme binding with low-affinity to proteins that are not endogenous substrates. Since it is not difficult to detect Dysbindin-Venus by Western blotting, the best experiment under the current circumstances might be to study thin mutant flys expressing low levels of Dysbindin-Venus. At this juncture, the reviewers do not require this experiment to be done. Instead, the authors should conservatively rephrase their conclusion that Dysbindin is regulated by the UPS in a Thin-dependent manner (Figure 6F) and might eliminate &quot;26S&quot; from Figure 6F and change the text accordingly.</p></disp-quote><p>We completely agree and rephrased our conclusions regarding Dysbindin regulation by the UPS throughout the text. We also directly address this point in the Results section:</p><p>&quot;Although we cannot exclude the possibility that Thin overexpression induced artificial Dysbindin ubiquitination by excess enzyme binding with low affinity, these data are consistent with the idea that Thin acts as an E3 ligase for Dysbindin in <italic>Drosophila</italic>, similar to TRIM32 in humans (Locke et al., 2009).&quot; (l. 330). Moreover, we eliminated the model shown in Figure 6F to avoid any confusion.</p><disp-quote content-type="editor-comment"><p>3. There appears to be a misunderstanding regarding the reviewers' comment C5 – the concerns regarding discrepancies between Figure 2C and Figure 4C. In the reviewers' view, the expression of thin should be the same in these two scenarios; no thin expression in presynapse but intact expression in postsynapse. There should not be any difference between the results in Figure 2C and Figure 4C. This issue should be explained and resolved.</p></disp-quote><p>We agree – in theory, postsynaptic thin rescue (Figure 2C) should produce a similar phenotype as presynaptic thin-RNAi expression (Figure 4C). Indeed, the increase in quantal content under baseline conditions is very similar between postsynaptic thin rescue (Figure 2E, light green bar) and presynaptic thin-RNAi expression (Figure 4D), in line with a model in which presynaptic thin perturbation increases quantal content in both genotypes. The smaller mEPSC and EPSC amplitudes under baseline conditions after postsynaptic thin rescue (Figure 2B, C) compared to thin-RNAi (Figure 4B, C) are most likely due to non-endogenous Thin levels caused by thin overexpression in the thinΔA mutant background. We now discuss this possibility in the main text: &quot;Note that the smaller mEPSC and EPSC amplitudes under baseline conditions after postsynaptic thin rescue (Figure 2B, C) compared to thin<sup>RNAi</sup> (Figure 4B, C) are most likely due to non-endogenous postsynaptic Thin levels caused by thin overexpression in the thin<sup>ΔA</sup> mutant background.&quot; (l. 256)</p><disp-quote content-type="editor-comment"><p>4. The identity of the transgenic lines shown in Figure 1E should be disclosed. The authors have done a good job of listing all genotypes. However, in its present form, the assignment of individual genotypes to data points on the volcano plot cannot be clearly extracted from the supplementary table. As a compromise, the authors could use the red colour code in the table as previously suggested (comment C1).</p></disp-quote><p>As suggested, we now labeled transgenic lines with significantly altered EPSC amplitude in red in the supplementary table and sorted the lines according to EPSC amplitude.</p><disp-quote content-type="editor-comment"><p>5. To avoid word repetition, the reviewers suggest slightly rephrasing the sentence &quot;Regarding the decrease in Brp intensity, Brp intensity was decreased…&quot; (lines 230-231).</p></disp-quote><p>We changed the text correspondingly: &quot;Furthermore, Brp intensity was decreased after presynaptic rescue (…).&quot; (l. 225).</p></body></sub-article></article>